{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T03:48:23Z","timestamp":1793936903114,"version":"4.8.0"},"reference-count":344,"publisher":"Bentham Science Publishers Ltd.","issue":"4","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>Sulfonamides constitute an important class of drugs, with many types of pharmacological agents possessing antibacterial, anti-carbonic anhydrase, anti-obesity, diuretic, hypoglycemic, antithyroid, antitumor, and anti-neuropathic pain activities. The sulfonamides have the general formula R-SO2NHR', in which the functional group is bound to an aromatic, heterocycle, aliphatic, and so on. The nature of the R and R' moiety is variable, starting with hydrogen and ranging to a variety of moieties incorporating organic compounds such as coumarin, isoxazole, tetrazole, pyrazole, pyrrole, and so many other pharmaceutical active scaffolds that lead to a considerable range of hybrids named as sulfonamide hybrids. Part A of this review presents the most recent advances in designing and developing two-component sulfonamide hybrids containing coumarin, indole, quinoline, isoquinoline, chalcone, pyrazole\/pyrazoline, quinazoline, pyrimidine, thiazole, benzothiazole, and pyridine between 2015 and 2020. Specifically, the authors review the scientific reports on the synthesis and biological activity of this kind of hybrid agent.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0929867329666220622153348","type":"journal-article","created":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T05:01:16Z","timestamp":1655960476000},"page":"407-480","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Recent Advances in Biological Active Sulfonamide based Hybrid\nCompounds Part A: Two-Component Sulfonamide Hybrids"],"prefix":"10.2174","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0839-0547","authenticated-orcid":true,"given":"Reihane","family":"Ghomashi","sequence":"first","affiliation":[{"name":"Department of Medicinal Chemistry, Shahreza Branch, Islamic Azad University, Shahreza, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1044-7298","authenticated-orcid":true,"given":"Shakila","family":"Ghomashi","sequence":"additional","affiliation":[{"name":"Department of Medicinal Chemistry, Shahreza Branch, Islamic Azad University, Shahreza, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2467-2728","authenticated-orcid":true,"given":"Hamidreza","family":"Aghaei","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Shahreza Branch, Islamic Azad University, Shahreza, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8843-3190","authenticated-orcid":true,"given":"Ahmad Reza","family":"Massah","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Shahreza Branch, Islamic Azad University, Shahreza, Isfahan, Iran"},{"name":"Razi Chemistry\nResearch Center (RCRC), Shahreza Branch, Islamic Azad University, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1517\/17460441.2016.1135125","volume":"11","author":"B&#xE9;rub&#xE9; G.","year":"2016","unstructured":"B&#xE9;rub&#xE9; G.; An overview of molecular hybrids in drug discovery. Expert Opin Drug Discov 2016,11(3),281-305","journal-title":"Expert Opin Drug Discov"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.drudis.2014.09.018","volume":"20","author":"Pandita D.","year":"2015","unstructured":"Pandita D.; Kumar S.; Lather V.; Hybrid poly (lactic-co-glycolic acid) nanoparticles: Design and delivery prospectives. Drug Discov Today 2015,20(1),95-104","journal-title":"Drug Discov Today"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.progpolymsci.2013.10.008","volume":"39","author":"Deng C.","year":"2014","unstructured":"Deng C.; Wu J.; Cheng R.; Meng F.; Klok H-A.; Zhong Z.; Functional polypeptide and hybrid materials: Precision synthesis via &#x3B1;-amino acid N-carboxyanhydride polymerization and emerging biomedical applications. Prog Polym Sci 2014,39(2),330-364","journal-title":"Prog Polym Sci"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1007\/s00044-014-1196-5","volume":"24","author":"Rana A.","year":"2015","unstructured":"Rana A.; Alex J.M.; Chauhan M.; Joshi G.; Kumar R.; A review on pharmacophoric designs of antiproliferative agents. Med Chem Res 2015,24(3),903-920","journal-title":"Med Chem Res"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1517\/13543776.2014.972368","volume":"24","author":"Katsori A-M.","year":"2014","unstructured":"Katsori A-M.; Hadjipavlou-Litina D.; Coumarin derivatives: An updated patent review (2012\u20132014). Expert Opin Ther Pat 2014,24(12),1323-1347","journal-title":"Expert Opin Ther Pat"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.ejmech.2014.03.018","volume":"77","author":"Nepali K.","year":"2014","unstructured":"Nepali K.; Sharma S.; Sharma M.; Bedi P.; Dhar K.; Rational approaches, design strategies, structure activity relationship and mechanistic insights for anticancer hybrids. Eur J Med Chem 2014,77,422-487","journal-title":"Eur J Med Chem"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1080\/17460441.2016.1187597","volume":"11","author":"Parkes A.L.","year":"2016","unstructured":"Parkes A.L.; Yule I.A.; Hybrid antibiotics\u2013clinical progress and novel designs. Expert Opin Drug Discov 2016,11(7),665-680","journal-title":"Expert Opin Drug Discov"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.2174\/156802611798184382","volume":"11","author":"Marco-Contelles J.","year":"2011","unstructured":"Marco-Contelles J.; Soriano E.; The medicinal chemistry of hybrid-based drugs targeting multiple sites of action. Curr Top Med Chem 2011,11(22),2714-2715","journal-title":"Curr Top Med Chem"},{"key":"ref=9","author":"Decker M.","year":"2017","unstructured":"Decker M.;  Design of hybrid molecules for drug development 2017","journal-title":"Design of hybrid molecules for drug development"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1021\/ar7000843","volume":"41","author":"Meunier B.","year":"2008","unstructured":"Meunier B.; Hybrid molecules with a dual mode of action: Dream or reality? Acc Chem Res 2008,41(1),69-77","journal-title":"Acc Chem Res"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.ejmech.2018.11.017","volume":"162","author":"Zhao C.","year":"2019","unstructured":"Zhao C.; Rakesh K.; Ravidar L.; Fang W-Y.; Qin H-L.; Pharmaceutical and medicinal significance of sulfur (SVI)-Containing motifs for drug discovery: A critical review. Eur J Med Chem 2019,162,679-734","journal-title":"Eur J Med Chem"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.3390\/molecules22101642","volume":"22","author":"Supuran C.T.","year":"2017","unstructured":"Supuran C.T.; Special issue: Sulfonamides. Molecules 2017,22(10),1642-1646","journal-title":"Molecules"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.ejmech.2016.08.060","volume":"124","author":"Ghorab M.M.","year":"2016","unstructured":"Ghorab M.M.; Alsaid M.S.; El-Gaby M.S.; Safwat N.A.; Elaasser M.M.; Soliman A.M.; Biological evaluation of some new N-(2, 6-dimethoxypyrimidinyl) thioureido benzenesulfonamide derivatives as potential antimicrobial and anticancer agents. Eur J Med Chem 2016,124,299-310","journal-title":"Eur J Med Chem"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.3109\/14756366.2016.1160077","volume":"31","author":"Gul H.I.","year":"2016","unstructured":"Gul H.I.; Tugrak M.; Sakagami H.; Taslimi P.; Gulcin I.; Supuran C.T.; Synthesis and bioactivity studies on new 4-(3-(4-Substitutedphenyl)-3a, 4-dihydro-3 H-indeno [1, 2-c] pyrazol-2-yl) benzenesulfonamides. J Enzyme Inhib Med Chem 2016,31(6),1619-1624","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"6600","DOI":"10.1002\/anie.201506818","volume":"55","author":"Chellat M.F.","year":"2016","unstructured":"Chellat M.F.; Ragu&#x17E; L.; Riedl R.; Targeting antibiotic resistance. Angew Chem Int Ed 2016,55(23),6600-6626","journal-title":"Angew Chem Int Ed"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"83438","DOI":"10.1039\/C6RA15948F","volume":"6","author":"Gao H-D.","year":"2016","unstructured":"Gao H-D.; Liu P.; Yang Y.; Gao F.; Sulfonamide-1, 3, 5-triazine\u2013thiazoles: Discovery of a novel class of antidiabetic agents via inhibition of DPP-4. RSC Advances 2016,6(86),83438-83447","journal-title":"RSC Advances"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"25584","DOI":"10.1039\/C6RA00846A","volume":"6","author":"Verma S.","year":"2016","unstructured":"Verma S.; Pandey S.; Agarwal P.; Verma P.; Deshpande S.; Saxena J.K.; Srivastava K.; Chauhan P.M.; Prabhakar Y.S.N.; -(7-Chloroquinolinyl-4-aminoalkyl) arylsulfonamides as antimalarial agents: Rationale for the activity with reference to inhibition of hemozoin formation. RSC Advances 2016,6(30),25584-25593","journal-title":"RSC Advances"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.bioorg.2015.11.002","volume":"64","author":"Mutahir S.","year":"2016","unstructured":"Mutahir S.; Jo\u0144czyk J.; Bajda M.; Khan I.U.; Khan M.A.; Ullah N.; Ashraf M.; Riaz S.; Hussain S.; Yar M.; Novel biphenyl bis-sulfonamides as acetyl and butyrylcholinesterase inhibitors: Synthesis, biological evaluation and molecular modeling studies. Bioorg Chem 2016,64,13-20","journal-title":"Bioorg Chem"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.bioorg.2016.07.006","volume":"68","author":"Mert S.","year":"2016","unstructured":"Mert S.; Al\u0131m Z.; \u0130&#x15F;g&#xF6;r M.M.; Beydemir &#x15E;.; Kas\u0131mo&#x11F;ullar\u0131 R.; The synthesis of novel pyrazole-3, 4-dicarboxamides bearing 5-amino-1, 3, 4-thiadiazole-2-sul fonamide moiety with effective inhibitory activity against the isoforms of human cytosolic carbonic anhydrase I and II. Bioorg Chem 2016,68,64-71","journal-title":"Bioorg Chem"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.bioorg.2016.12.007","volume":"70","author":"Durgun M.","year":"2017","unstructured":"Durgun M.; Turkmen H.; Zengin G.; Zengin H.; Koyunsever M.; Koyuncu I.; Synthesis, characterization, in vitro cytotoxicity and antimicrobial investigation and evaluation of physicochemical properties of novel 4-(2-methylacetamide) benzenesulfonamide derivatives. Bioorg Chem 2017,70,163-172","journal-title":"Bioorg Chem"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1016\/j.bmcl.2017.03.018","volume":"27","author":"Alaoui S.","year":"2017","unstructured":"Alaoui S.; Dufies M.; Driowya M.; Demange L.; Bougrin K.; Robert G.; Auberger P.; Pag&#xE8;s G.; Benhida R.; Synthesis and anti-cancer activities of new sulfonamides 4-substituted-triazolyl nucleosides. Bioorg Med Chem Lett 2017,27(9),1989-1992","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"4584","DOI":"10.1021\/acs.jmedchem.6b01727","volume":"60","author":"Frkic R.L.","year":"2017","unstructured":"Frkic R.L.; He Y.; Rodriguez B.B.; Chang M.R.; Kuruvilla D.; Ciesla A.; Abell A.D.; Kamenecka T.M.; Griffin P.R.; Bruning J.B.; Structure\u2013activity relationship of 2, 4-dichloro-N-(3, 5-dichloro-4-(quinolin-3-yloxy) phenyl) benzenesulfonamide (INT131) analogs for PPAR&#x3B3;-targeted antidiabetics. J Med Chem 2017,60(11),4584-4593","journal-title":"J Med Chem"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"13516","DOI":"10.1039\/C7NJ03332J","volume":"41","author":"Gorantla V.","year":"2017","unstructured":"Gorantla V.; Gundla R.; Jadav S.S.; Anugu S.R.; Chimakurthy J.; Nidasanametla S.K.; Korupolu R.; Molecular hybrid design, synthesis and biological evaluation of N-phenyl sulfonamide linked N-acyl hydrazone derivatives functioning as COX-2 inhibitors: New anti-inflammatory, anti-oxidant and anti-bacterial agents. New J Chem 2017,41(22),13516-13532","journal-title":"New J Chem"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.bmc.2016.11.032","volume":"25","author":"Ko\u0161ak U.","year":"2017","unstructured":"Ko\u0161ak U.; Knez D.; Coquelle N.; Brus B.; Pi\u0161lar A.; Nachon F.; Brazzolotto X.; Kos J.; Colletier J-P.; Gobec S.; N-Propargylpiperidines with naphthalene-2-carboxamide or naphthalene-2-sulfonamide moieties: Potential multifunctional anti-Alzheimer\u2019s agents. Bioorg Med Chem 2017,25(2),633-645","journal-title":"Bioorg Med Chem"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1016\/j.bmc.2017.01.032","volume":"25","author":"Alaa A-M.","year":"2017","unstructured":"Alaa A-M.; Angeli A.; El-Azab A.S.; El-Enin M.A.A.; Supuran C.T.; Synthesis and biological evaluation of cyclic imides incorporating benzenesulfonamide moieties as carbonic anhydrase I, II, IV and IX inhibitors. Bioorg Med Chem 2017,25(5),1666-1671","journal-title":"Bioorg Med Chem"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.bioorg.2017.01.008","volume":"71","author":"Bhatti H.A.","year":"2017","unstructured":"Bhatti H.A.; Khatoon M.; Al-Rashida M.; Bano H.; Iqbal N.; Yousuf S.; Khan K.M.; Hameed A.; Iqbal J.; Facile dimethyl amino group triggered cyclic sulfonamides synthesis and evaluation as alkaline phosphatase inhibitors. Bioorg Chem 2017,71,10-18","journal-title":"Bioorg Chem"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1002\/jccs.201800207","volume":"66","author":"Mohebali F.","year":"2019","unstructured":"Mohebali F.; Nazifi Z.; Mohamad Reza Nazifi S.; Mohammadian H.; Massah A.R.; Synthesis, molecular docking studies, and absorption, distribution, metabolism, and excretion prediction of novel sulfonamide derivatives as antibacterial agents. J Chin Chem Soc (Taipei) 2019,66(5),558-566","journal-title":"J Chin Chem Soc (Taipei)"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"111","DOI":"10.2174\/1570178614666170707152357","volume":"15","author":"Beheshti-Maal K.","year":"2018","unstructured":"Beheshti-Maal K.; Khazaeili T.; Asakere N.; Mousavi F.; Massah A.; Synthesis of some novel sulfonamide-imines as potential antimicrobial agents. Lett Org Chem 2018,15(2),111-117","journal-title":"Lett Org Chem"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3184\/174751915X14241022318075","volume":"39","author":"Maghsoodi N.K.","year":"2015","unstructured":"Maghsoodi N.K.; Khazaeli T.; Massah A.R.; Solvent-free synthesis of novel styrenesulfonamide derivatives and evaluation of their antibacterial activity. J Chem Res 2015,39(3),141-144","journal-title":"J Chem Res"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1080\/14756366.2020.1715387","volume":"35","author":"Poole A.T.","year":"2020","unstructured":"Poole A.T.; Sitko C.A.; Le C.; Naus C.C.; Hill B.M.; Bushnell E.A.; Chen V.C.; Examination of sulfonamide-based inhibitors of MMP3 using the conditioned media of invasive glioma cells. J Enzyme Inhib Med Chem 2020,35(1),672-681","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"104845","DOI":"10.1016\/j.neuint.2020.104845","volume":"140","author":"Lu C.W.","year":"2020","unstructured":"Lu C.W.; Lin T-Y.; Yang H.C.; Hung C.F.; Weng J.R.; Wang S.J.; [1-(4-chloro-3-nitrobenzenesulfonyl)-1H-indol-3-yl]-methanol, an indole-3-carbinol derivative, inhibits glutamate release in rat cerebrocortical nerve terminals by suppressing the P\/Q-type Ca2+ channels and Ca2+\/calmodulin\/protein kinase A pathway. Neurochem Int 2020,140,104845","journal-title":"Neurochem Int"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"5465","DOI":"10.1016\/j.bmc.2008.04.011","volume":"16","author":"Massah A.R.","year":"2008","unstructured":"Massah A.R.; Adibi H.; Khodarahmi R.; Abiri R.; Majnooni M.B.; Shahidi S.; Asadi B.; Mehrabi M.; Zolfigol M.A.; Synthesis, in vitro antibacterial and carbonic anhydrase II inhibitory activities of N-acylsulfonamides using silica sulfuric acid as an efficient catalyst under both solvent-free and heterogeneous conditions. Bioorg Med Chem 2008,16(10),5465-5472","journal-title":"Bioorg Med Chem"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"132132","DOI":"10.1016\/j.matlet.2022.132132","volume":"317","author":"Ghomashi R.","year":"2022","unstructured":"Ghomashi R.; Rabiei M.; Ghomashi S.; Reza Massah A.; Kolahdoozan M.; Hosseinnezhad M.; Ebrahimi-Kahrizsangi R.; Palevicius A.; Nasiri S.; Janusas G.; Synthesis and investigation of the theoretical and experimental optical properties of some novel azo pyrazole sulfonamide hybrids. Mater Lett 2022,317,132132","journal-title":"Mater Lett"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1080\/00397910903318732","volume":"40","author":"Adibi H.","year":"2010","unstructured":"Adibi H.; Massah A.R.; Majnooni M.B.; Shahidi S.; Afshar M.; Abiri R.; Naghash H.J.; Synthesis, characterization, and antimicrobial evaluation of sulfonamides containing n-acyl moieties catalyzed by bismuth (III) salts under both solvent and solvent-free conditions. Synth Commun 2010,40(18),2753-2766","journal-title":"Synth Commun"},{"key":"ref=35","first-page":"25","volume":"5","author":"Massah A.R.","unstructured":"Massah A.R.; Dakhilpour S.S.; Ebrahimi S.; Naseri S.; Nateghi M.; Mild and solvent-free synthesis and antibacterial evaluation of novel sulfonamides containing hydroxyl groups. Org Chem Res ,5(1),25-31","journal-title":"Org Chem Res"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"235","DOI":"10.2174\/157017806775789886","volume":"3","author":"Massah A.R.","year":"2006","unstructured":"Massah A.R.; Kazemi F.; Azadi D.; Farzaneh S.; Aliyan H.; Naghash H.J.; Momeni A.; A mild and chemoselective solvent-free method for the synthesis of N-aryl and N-alkylsulfonamides. Lett Org Chem 2006,3(3),235-241","journal-title":"Lett Org Chem"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1517\/13543776.2012.698264","volume":"22","author":"Carta F.","year":"2012","unstructured":"Carta F.; Scozzafava A.; Supuran C.T.; Sulfonamides: A patent review (2008\u20132012). Expert Opin Ther Pat 2012,22(7),747-758","journal-title":"Expert Opin Ther Pat"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1016\/j.bmcl.2005.03.032","volume":"15","author":"De Simone G.","year":"2005","unstructured":"De Simone G.; Di Fiore A.; Menchise V.; Pedone C.; Antel J.; Casini A.; Scozzafava A.; Wurl M.; Supuran C.T.; Carbonic anhydrase inhibitors. Zonisamide is an effective inhibitor of the cytosolic isozyme II and mitochondrial isozyme V: Solution and X-ray crystallographic studies. Bioorg Med Chem Lett 2005,15(9),2315-2320","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.bmc.2008.12.023","volume":"17","author":"Temperini C.","year":"2009","unstructured":"Temperini C.; Cecchi A.; Scozzafava A.; Supuran C.T.; Carbonic anhydrase inhibitors. Comparison of chlorthalidone, indapamide, trichloromethiazide, and furosemide X-ray crystal structures in adducts with isozyme II, when several water molecules make the difference. Bioorg Med Chem 2009,17(3),1214-1221","journal-title":"Bioorg Med Chem"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"4851","DOI":"10.1016\/j.bmcl.2009.06.022","volume":"19","author":"Ahlskog J.K.","year":"2009","unstructured":"Ahlskog J.K.; Dumelin C.E.; Tr&#xFC;ssel S.; M&#xE5;rlind J.; Neri D.; In vivo targeting of tumor-associated carbonic anhydrases using acetazolamide derivatives. Bioorg Med Chem Lett 2009,19(16),4851-4856","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1517\/13543776.2013.794788","volume":"23","author":"Masini E.","year":"2013","unstructured":"Masini E.; Carta F.; Scozzafava A.; Supuran C.T.; Antiglaucoma carbonic anhydrase inhibitors: A patent review. Expert Opin Ther Pat 2013,23(6),705-716","journal-title":"Expert Opin Ther Pat"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3109\/14756366.2011.597749","volume":"27","author":"Fabrizi F.","year":"2012","unstructured":"Fabrizi F.; Mincione F.; Somma T.; Scozzafava G.; Galassi F.; Masini E.; Impagnatiello F.; Supuran C.T.; A new approach to antiglaucoma drugs: Carbonic anhydrase inhibitors with or without NO donating moieties. Mechanism of action and preliminary pharmacology. J Enzyme Inhib Med Chem 2012,27(1),138-147","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1212\/WNL.0b013e31823a0cb6","volume":"77","author":"Matthews E.","year":"2011","unstructured":"Matthews E.; Portaro S.; Ke Q.; Sud R.; Haworth A.; Davis M.; Griggs R.; Hanna M.; Acetazolamide efficacy in hypokalemic periodic paralysis and the predictive role of genotype. Neurology 2011,77(22),1960-1964","journal-title":"Neurology"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"4866","DOI":"10.1016\/j.bmcl.2007.06.044","volume":"17","author":"Temperini C.","year":"2007","unstructured":"Temperini C.; Innocenti A.; Mastrolorenzo A.; Scozzafava A.; Supuran C.T.; Carbonic anhydrase inhibitors. Interaction of the antiepileptic drug sulthiame with twelve mammalian isoforms: Kinetic and X-ray crystallographic studies. Bioorg Med Chem Lett 2007,17(17),4866-4872","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.bmcl.2003.11.014","volume":"14","author":"Abbate F.","year":"2004","unstructured":"Abbate F.; Coetzee A.; Casini A.; Ciattini S.; Scozzafava A.; Supuran C.T.; Carbonic anhydrase inhibitors: X-ray crystallographic structure of the adduct of human isozyme II with the antipsychotic drug sulpiride. Bioorg Med Chem Lett 2004,14(2),337-341","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1021\/jm030912m","volume":"47","author":"Weber A.","year":"2004","unstructured":"Weber A.; Casini A.; Heine A.; Kuhn D.; Supuran C.T.; Scozzafava A.; Klebe G.; Unexpected nanomolar inhibition of carbonic anhydrase by COX-2-selective celecoxib: New pharmacological opportunities due to related binding site recognition. J Med Chem 2004,47(3),550-557","journal-title":"J Med Chem"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1039\/b800767e","volume":"6","author":"Temperini C.","year":"2008","unstructured":"Temperini C.; Cecchi A.; Scozzafava A.; Supuran C.T.; Carbonic anhydrase inhibitors. Sulfonamide diuretics revisited-old leads for new applications? Org Biomol Chem 2008,6(14),2499-2506","journal-title":"Org Biomol Chem"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1016\/j.bmcl.2008.03.051","volume":"18","author":"Temperini C.","year":"2008","unstructured":"Temperini C.; Cecchi A.; Scozzafava A.; Supuran C.T.; Carbonic anhydrase inhibitors. Interaction of indapamide and related diuretics with 12 mammalian isozymes and X-ray crystallographic studies for the indapamide\u2013isozyme II adduct. Bioorg Med Chem Lett 2008,18(8),2567-2573","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1021\/jm801386n","volume":"52","author":"Temperini C.","year":"2009","unstructured":"Temperini C.; Cecchi A.; Scozzafava A.; Supuran C.T.; Carbonic anhydrase inhibitors. Comparison of chlorthalidone and indapamide X-ray crystal structures in adducts with isozyme II: When three water molecules and the keto- enol tautomerism make the difference. J Med Chem 2009,52(2),322-328","journal-title":"J Med Chem"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"641","DOI":"10.2174\/138161208783877947","volume":"14","author":"Supuran C.T.","year":"2008","unstructured":"Supuran C.T.; Diuretics: From classical carbonic anhydrase inhibitors to novel applications of the sulfonamides. Curr Pharm Des 2008,14(7),641-648","journal-title":"Curr Pharm Des"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1159\/000103279","volume":"30","author":"Piecha G.","year":"2007","unstructured":"Piecha G.; Adamczak M.; Chudek J.; Wiecek A.; Indapamide decreases plasma adiponectin concentration in patients with essential hypertension. Kidney Blood Press Res 2007,30(3),187-194","journal-title":"Kidney Blood Press Res"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1007\/s00044-020-02528-1","volume":"29","author":"Irfan M.","year":"2020","unstructured":"Irfan M.; Selective cyclooxygenase-2 inhibitors: A review of recent chemical scaffolds with promising anti-inflammatory and COX-2 inhibitory activities. Med Chem Res 2020,29(5),809-830","journal-title":"Med Chem Res"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"818","DOI":"10.2174\/1385272822666180122153839","volume":"22","author":"Khan F.A.","year":"2018","unstructured":"Khan F.A.; Mushtaq S.; Naz S.; Farooq U.; Zaidi A.; Bukhari S.M.; Rauf A.; Mubarak M.S.; Sulfonamides as potential bioactive scaffolds. Curr Org Chem 2018,22(8),818-830","journal-title":"Curr Org Chem"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"488","DOI":"10.2174\/1871520617666171103140749","volume":"18","author":"Rakesh K.","year":"2018","unstructured":"Rakesh K.; Wang S-M.; Leng J.; Ravindar L.; Asiri A.M.; Marwani H.M.; Qin H-L.; Recent development of sulfonyl or sulfonamide hybrids as potential anticancer agents: A key review. Anticancer Agents Med Chem 2018,18(4),488-505","journal-title":"Anticancer Agents Med Chem"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1007\/s00044-019-02378-6","volume":"28","author":"Elgemeie G.H.","year":"2019","unstructured":"Elgemeie G.H.; Azzam R.A.; Elsayed R.E.; Sulfa drug analogs: New classes of N-sulfonyl aminated azines and their biological and preclinical importance in medicinal chemistry (2000\u20132018). Med Chem Res 2019,28(8),1099-1131","journal-title":"Med Chem Res"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"104400","DOI":"10.1016\/j.bioorg.2020.104400","volume":"105","author":"Verma S.K.","year":"2020","unstructured":"Verma S.K.; Verma R.; Xue F.; Thakur P.K.; Girish Y.; Rakesh K.; Antibacterial activities of sulfonyl or sulfonamide containing heterocyclic derivatives and its structure-activity relationships (SAR) studies: A critical review. Bioorg Chem 2020,105,104400","journal-title":"Bioorg Chem"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"131662","DOI":"10.1016\/j.tet.2020.131662","volume":"76","author":"Mondal S.","year":"2020","unstructured":"Mondal S.; Malakar S.; Synthesis of sulfonamide and their synthetic and therapeutic applications: Recent advances. Tetrahedron 2020,76(48),131662","journal-title":"Tetrahedron"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1080\/13543776.2018.1487400","volume":"28","author":"Gul&#xE7;in \u0130.","year":"2018","unstructured":"Gul&#xE7;in \u0130.; Taslimi P.; Sulfonamide inhibitors: A patent review 2013-present. Expert Opin Ther Pat 2018,28(7),541-549","journal-title":"Expert Opin Ther Pat"},{"key":"ref=59","first-page":"1","volume":"6","author":"Lavanya R.","year":"2017","unstructured":"Lavanya R.; Sulphonamides: A pharmaceutical review. Int J Pharm Sci Invent 2017,6(2),1-3","journal-title":"Int J Pharm Sci Invent"},{"key":"ref=60","first-page":"257","volume":"7","author":"Irfan A.","year":"2018","unstructured":"Irfan A.; Batool F.; Irum S.; Ullah S.; Umer M.; Shaheen R.; Chand A.J.; A therapeutic journey of sulfonamid derivatives as potent anticancer agents: A review. World J Pharm Res 2018,7,257-270","journal-title":"World J Pharm Res"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1016\/j.scitotenv.2018.06.016","volume":"640","author":"Chen J.","year":"2018","unstructured":"Chen J.; Xie S.; Overview of sulfonamide biodegradation and the relevant pathways and microorganisms. Sci Total Environ 2018,640,1465-1477","journal-title":"Sci Total Environ"},{"key":"ref=62","first-page":"5289","volume":"63","author":"El-Gaby M.","year":"2020","unstructured":"El-Gaby M.; Ammar A.Y.; IH El-Qaliei; M.; M Ali, A.; F Hussein, M.; A Faraghally, F. Sulfonamides: Synthesis and the recent applications in medicinal chemistry. Egypt J Chem 2020,63(12),5289-5327","journal-title":"Egypt J Chem"},{"key":"ref=63","first-page":"70","volume":"7","author":"Parveen B.","year":"2017","unstructured":"Parveen B.; Praveen S.; Pal H.; A short review on sulphonamides with antimicrobial activity. Int J Pharm Chem 2017,7(05),70-73","journal-title":"Int J Pharm Chem"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"112923","DOI":"10.1016\/j.ejmech.2020.112923","volume":"209","author":"Kumar S.","year":"2021","unstructured":"Kumar S.; Rulhania S.; Jaswal S.; Monga V.; Recent advances in the medicinal chemistry of carbonic anhydrase inhibitors. Eur J Med Chem 2021,209,112923","journal-title":"Eur J Med Chem"},{"key":"ref=65","first-page":"194","volume":"8","author":"Das T.C.","year":"2018","unstructured":"Das T.C.; Quadri S.A.; Farooqui M.; Recent advances in synthesis of sulfonamides: A review. Chem Biol Interact 2018,8(4),194-204","journal-title":"Chem Biol Interact"},{"key":"ref=66","first-page":"113","volume":"18","author":"Dubey P.K.","year":"2017","unstructured":"Dubey P.K.; Srikrishna D.; Chandraiah G.; A review on pharmacological properties of coumarins. Mini Rev Med Chem 2017,18(2),113-141","journal-title":"Mini Rev Med Chem"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11094-018-1756-y","volume":"52","author":"Mostajeran N.","year":"2018","unstructured":"Mostajeran N.; Arshad F.A.; Aliyan H.; Massah A.R.; Solvent-free synthesis and antibacterial evaluation of novel coumarin sulfonamides. Pharm Chem J 2018,52(1),1-7","journal-title":"Pharm Chem J"},{"key":"ref=68","first-page":"56","volume":"3","author":"Anjum N.F.","year":"2011","unstructured":"Anjum N.F.; Aleem A.; Nayeem N.; Asdaq S.; Synthesis and antibacterial activity of substituted 2-phenyl-4-chromones. Der Pharma Chem 2011,3,56-62","journal-title":"Der Pharma Chem"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1515\/znc-2005-9-1006","volume":"60","author":"de Souza S.M.","year":"2005","unstructured":"de Souza S.M.; Delle Monache F.; Sm&#xE2;nia A.; Antibacterial activity of coumarins. Z Naturforsch C J Biosci 2005,60(9-10),693-700","journal-title":"Z Naturforsch C J Biosci"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.13005\/ojc\/300433","volume":"30","author":"Behrami A.","year":"2014","unstructured":"Behrami A.; Antibacterial activity of coumarine derivatives synthesized from 4-Chloro-chromen-2-one. The comparison with standard drug. Orient J Chem 2014,30(4),1747-1752","journal-title":"Orient J Chem"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"e342","DOI":"10.1371\/journal.pmed.0020342","volume":"2","author":"Greaves M.","year":"2005","unstructured":"Greaves M.; Pharmacogenetics in the management of coumarin anticoagulant therapy: The way forward or an expensive diversion? PLoS Med 2005,2(10),e342","journal-title":"PLoS Med"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1039\/C4RA11733F","volume":"5","author":"Mazzone G.","year":"2015","unstructured":"Mazzone G.; Malaj N.; Galano A.; Russo N.; Toscano M.; Antioxidant properties of several coumarin\u2013chalcone hybrids from theoretical insights. RSC Advances 2015,5(1),565-575","journal-title":"RSC Advances"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.3390\/ijms14011293","volume":"14","author":"De Ara&#xFA;jo R.S.","year":"2013","unstructured":"De Ara&#xFA;jo R.S.; Guerra F.Q.; Lima D.O.; De Simone C.A.; Tavares J.F.; Scotti L.; Scotti M.T.; De Aquino T.M.; De Moura R.O.; Mendon&#xE7;a F.J.; Synthesis, structure-activity relationships (SAR) and in silico studies of coumarin derivatives with antifungal activity. Int J Mol Sci 2013,14(1),1293-1309","journal-title":"Int J Mol Sci"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1515\/hc-2020-0008","volume":"26","author":"Irfan A.","year":"2020","unstructured":"Irfan A.; Rubab L.; Rehman M.U.; Anjum R.; Ullah S.; Marjana M.; Qadeer S.; Sana S.; Coumarin sulfonamide derivatives: An emerging class of therapeutic agents. Heterocycl Commun 2020,26(1),46-59","journal-title":"Heterocycl Commun"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s13738-021-02344-3","volume":"19","author":"Aminarshad F.","year":"2022","unstructured":"Aminarshad F.; Heidari S.; Mostajeran N.; Massah A.R.; Design, solvent-free synthesis and antibacterial activity evaluation of new coumarin sulfonamides. J Iran Chem Soc 2022,19(2),547-562","journal-title":"J Iran Chem Soc"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-99618-w","volume":"11","author":"Esfahani S.N.","year":"2021","unstructured":"Esfahani S.N.; Damavandi M.S.; Sadeghi P.; Nazifi Z.; Salari-Jazi A.; Massah A.R.; Synthesis of some novel coumarin isoxazol sulfonamide hybrid compounds, 3D-QSAR studies, and antibacterial evaluation. Sci Rep 2021,11(1),1-15","journal-title":"Sci Rep"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1016\/j.tetlet.2015.02.087","volume":"56","author":"Farahi M.","year":"2015","unstructured":"Farahi M.; Karami B.; Tanuraghaj H.M.; Efficient synthesis of a new class of sulfonamide-substituted coumarins. Tetrahedron Lett 2015,56(14),1833-1836","journal-title":"Tetrahedron Lett"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1111\/php.12985","volume":"95","author":"Wijesooriya C.S.","year":"2019","unstructured":"Wijesooriya C.S.; Nieszala M.; Stafford A.; Zimmerman J.R.; Smith E.A.; Coumarin\u2010based fluorescent probes for selectively targeting and imaging the endoplasmic reticulum in mammalian cells. Photochem Photobiol 2019,95(2),556-562","journal-title":"Photochem Photobiol"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.molstruc.2018.01.007","volume":"1158","author":"Prathap K.C.","year":"2018","unstructured":"Prathap K.C.; Lokanath N.; Synthesis, characterization, crystal structure and quantum chemical investigations of three novel coumarin-benzenesulfonohydrazide derivatives. J Mol Struct 2018,1158,26-38","journal-title":"J Mol Struct"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"3251","DOI":"10.3390\/molecules25143251","volume":"25","author":"Alshibl H.M.","year":"2020","unstructured":"Alshibl H.M.; Al-Abdullah E.S.; Haiba M.E.; Alkahtani H.M.; Awad G.E.; Mahmoud A.H.; Ibrahim B.M.; Bari A.; Villinger A.; Synthesis and evaluation of new coumarin derivatives as antioxidant, antimicrobial, and anti-inflammatory agents. Molecules 2020,25(14),3251","journal-title":"Molecules"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.1016\/j.bmc.2016.04.052","volume":"24","author":"Chandak N.","year":"2016","unstructured":"Chandak N.; Ceruso M.; Supuran C.T.; Sharma P.K.; Novel sulfonamide bearing coumarin scaffolds as selective inhibitors of tumor associated carbonic anhydrase isoforms IX and XII. Bioorg Med Chem 2016,24(13),2882-2886","journal-title":"Bioorg Med Chem"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1080\/14756366.2018.1477137","volume":"33","author":"Sabt A.","year":"2018","unstructured":"Sabt A.; Abdelhafez O.M.; El-Haggar R.S.; Madkour H.M.; Eldehna W.M.; El-Khrisy E.E-D.A.; Abdel-Rahman M.A.; Rashed L.A.; Novel coumarin-6-sulfonamides as apoptotic anti-proliferative agents: Synthesis, in vitro biological evaluation, and QSAR studies. J Enzyme Inhib Med Chem 2018,33(1),1095-1107","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=83","first-page":"120","volume":"142","author":"Meena L.R.","year":"2020","unstructured":"Meena L.R.; Sharma V.S.; Swarnkar P.; Synthesis and biological activity of novel sulfonamides derivatives of various heterocyclic compounds. World Sci News 2020,142,120-134","journal-title":"World Sci News"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1080\/14756366.2016.1217851","volume":"31","author":"Debbabi K.F.","year":"2016","unstructured":"Debbabi K.F.; Al-Harbi S.A.; Al-Saidi H.M.; Aljuhani E.H.; Abd El-Gilil S.M.; Bashandy M.S.; Study of reactivity of cyanoacetohydrazonoethyl-N-ethyl-N-methyl benzenesulfonamide: Preparation of novel anticancer and antimicrobial active heterocyclic benzenesulfonamide derivatives and their molecular docking against dihydrofolate reductase. J Enzyme Inhib Med Chem 2016,31(sup4),7-19","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1007\/s00044-019-02431-4","volume":"28","author":"Taha M.","year":"2019","unstructured":"Taha M.; Noreen T.; Imran S.; Nawaz F.; Chigurupati S.; Selvaraj M.; Rahim F.; Hadiani Ismail N.; Kumar A.; Mosaddik A.; Alghamdi A.M.; Abdulrahman nasser alqahtani, Y.; Abdulrahman nasser alqahtani, A. Abdulrahman nasser alqahtani, Y.; Abdulrahman nasser alqahtani, A., Synthesis, &#x3B1;-amylase inhibition and molecular docking study of bisindolylmethane sulfonamide derivatives. Med Chem Res 2019,28(11),2010-2022","journal-title":"Med Chem Res"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ejmech.2011.11.028","volume":"48","author":"Sharma S.K.","year":"2012","unstructured":"Sharma S.K.; Kumar P.; Narasimhan B.; Ramasamy K.; Mani V.; Mishra R.K.; Majeed A.B.A.; Synthesis, antimicrobial, anticancer evaluation and QSAR studies of 6-methyl-4-[1-(2-substituted-phenylamino-acetyl)-1H-indol-3-yl]-2-oxo\/thioxo-1, 2, 3, 4-tetrahydropyrimidine-5-carbo-] xylic acid ethyl esters. Eur J Med Chem 2012,48,16-25","journal-title":"Eur J Med Chem"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"11149","DOI":"10.1021\/acs.jmedchem.0c01116","volume":"63","author":"Zhou H-S.","year":"2020","unstructured":"Zhou H-S.; Hu L-B.; Zhang H.; Shan W-X.; Wang Y.; Li X.; Liu T.; Zhao J.; You Q-D.; Jiang Z-Y.; Design, synthesis, and structure\u2013activity relationships of Indoline-Based Kelch-like ECH-Associated Protein 1-Nuclear Factor (Erythroid-Derived 2)-Like 2 (Keap1-Nrf2) Protein\u2013Protein Interaction Inhibitors. J Med Chem 2020,63(19),11149-11168","journal-title":"J Med Chem"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.2147\/IDR.S208757","volume":"12","author":"Yuan W.","year":"2019","unstructured":"Yuan W.; Yu Z.; Song W.; Li Y.; Fang Z.; Zhu B.; Li X.; Wang H.; Hong W.; Sun N.; Indole-core-based novel antibacterial agent targeting FtsZ. Infect Drug Resist 2019,12,2283-2296","journal-title":"Infect Drug Resist"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"111691","DOI":"10.1016\/j.ejmech.2019.111691","volume":"183","author":"Wan Y.","year":"2019","unstructured":"Wan Y.; Li Y.; Yan C.; Yan M.; Tang Z.; Indole: A privileged scaffold for the design of anti-cancer agents. Eur J Med Chem 2019,183,111691","journal-title":"Eur J Med Chem"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ejmech.2016.03.021","volume":"115","author":"Zhu W.","year":"2016","unstructured":"Zhu W.; Bao X.; Ren H.; Da Y.; Wu D.; Li F.; Yan Y.; Wang L.; Chen Z.; N-Phenyl indole derivatives as AT1 antagonists with anti-hypertension activities: Design, synthesis and biological evaluation. Eur J Med Chem 2016,115,161-178","journal-title":"Eur J Med Chem"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ejmech.2019.02.019","volume":"168","author":"Luthra T.","year":"2019","unstructured":"Luthra T.; Nayak A.K.; Bose S.; Chakrabarti S.; Gupta A.; Sen S.; Indole based antimalarial compounds targeting the melatonin pathway: Their design, synthesis and biological evaluation. Eur J Med Chem 2019,168,11-27","journal-title":"Eur J Med Chem"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13065-020-00691-5","volume":"14","author":"Ibrahim M.","year":"2020","unstructured":"Ibrahim M.; Taha M.; Almandil N.B.; Kawde A-N.; Nawaz M.; Synthesis, characterization and electrochemical properties of some biologically important indole-based-sulfonamide derivatives. BMC Chem 2020,14(1),1-10","journal-title":"BMC Chem"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"3317","DOI":"10.2174\/138161210793429805","volume":"16","author":"Guzela O.","year":"2010","unstructured":"Guzela O.; Innocenti A.; Vullo D.; Scozzafava A.; Supuran T.C.; 3-phenyl-1H-indole-5-sulfonamides: Structure-based drug design of a promising class of carbonic anhydrase inhibitors. Curr Pharm Des 2010,16(29),3317-3326","journal-title":"Curr Pharm Des"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.3390\/ijms20092354","volume":"20","author":"Bua S.","year":"2019","unstructured":"Bua S.; Akg&#xFC;ne&#x15F; N.M.; Akdemir A.; Supuran C.T.; G&#xFC;zel-Akdemir &#xD6;.; Indole-based hydrazones containing a sulfonamide moiety as selective inhibitors of tumor-associated human carbonic anhydrase isoforms IX and XII. Int J Mol Sci 2019,20(9),2354","journal-title":"Int J Mol Sci"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s11030-013-9457-7","volume":"17","author":"Pingaew R.","year":"2013","unstructured":"Pingaew R.; Prachayasittikul S.; Ruchirawat S.; Prachayasittikul V.; Synthesis and structure\u2013activity relationship of mono-indole-, bis-indole-, and tris-indole-based sulfonamides as potential anticancer agents. Mol Divers 2013,17(3),595-604","journal-title":"Mol Divers"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1039\/C6MD00255B","volume":"7","author":"Man R-J.","year":"2016","unstructured":"Man R-J.; Tang D-J.; Lu X-Y.; Duan Y-T.; Tao X-X.; Yang M-R.; Wang L-L.; Wang B-Z.; Xu C.; Zhu H-L.; Synthesis and biological evaluation of novel indole derivatives containing sulfonamide scaffold as potential tubulin inhibitor. MedChemComm 2016,7(9),1759-1767","journal-title":"MedChemComm"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.bmcl.2018.12.013","volume":"29","author":"Wu Y-J.","year":"2019","unstructured":"Wu Y-J.; Venables B.; Guernon J.; Chen J.; Sit S-Y.; Rajamani R.; Knox R.J.; Matchett M.; Pieschl R.L.; Herrington J.; Bristow L.J.; Meanwell N.A.; Thompson L.A.; Dzierba C.; Discovery of new indole-based acylsulfonamide Nav1. 7 inhibitors. Bioorg Med Chem Lett 2019,29(4),659-663","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"111815","DOI":"10.1016\/j.ejmech.2019.111815","volume":"185","author":"Fantacuzzi M.","year":"2020","unstructured":"Fantacuzzi M.; De Filippis B.; Gallorini M.; Ammazzalorso A.; Giampietro L.; Maccallini C.; Aturki Z.; Donati E.; Ibrahim R.S.; Shawky E.; Cataldi A.; Amoroso R.; Synthesis, biological evaluation, and docking study of indole aryl sulfonamides as aromatase inhibitors. Eur J Med Chem 2020,185,111815","journal-title":"Eur J Med Chem"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"6607","DOI":"10.1021\/acs.jmedchem.5b00736","volume":"58","author":"Luz J.G.","year":"2015","unstructured":"Luz J.G.; Carson M.W.; Condon B.; Clawson D.; Pustilnik A.; Kohlman D.T.; Barr R.J.; Bean J.S.; Dill M.J.; Sindelar D.K.; Maletic M.; Coghlan M.J.; Indole glucocorticoid receptor antagonists active in a model of dyslipidemia act via a unique association with an agonist binding site. J Med Chem 2015,58(16),6607-6618","journal-title":"J Med Chem"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1016\/j.ejmech.2017.10.057","volume":"143","author":"Pingaew R.","year":"2018","unstructured":"Pingaew R.; Mandi P.; Prachayasittikul V.; Prachayasittikul S.; Ruchirawat S.; Prachayasittikul V.; Synthesis, molecular docking, and QSAR study of sulfonamide-based indoles as aromatase inhibitors. Eur J Med Chem 2018,143,1604-1615","journal-title":"Eur J Med Chem"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1080\/14756366.2018.1446432","volume":"33","author":"Awadallah F.M.","year":"2018","unstructured":"Awadallah F.M.; Bua S.; Mahmoud W.R.; Nada H.H.; Nocentini A.; Supuran C.T.; Inhibition studies on a panel of human carbonic anhydrases with N 1-substituted secondary sulfonamides incorporating thiazolinone or imidazolone-indole tails. J Enzyme Inhib Med Chem 2018,33(1),629-638","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3390\/antibiotics9090595","volume":"9","author":"Reidl C.T.","year":"2020","unstructured":"Reidl C.T.; Heath T.K.; Darwish I.; Torrez R.M.; Moore M.; Gild E.; Nocek B.P.; Starus A.; Holz R.C.; Becker D.P.; Indoline-6-sulfonamide inhibitors of the bacterial enzyme DapE. Antibiotics (Basel) 2020,9(9),595","journal-title":"Antibiotics (Basel)"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1016\/j.bmc.2017.02.014","volume":"25","author":"Liu T.","year":"2017","unstructured":"Liu T.; Wan Y.; Liu R.; Ma L.; Li M.; Fang H.; Design, synthesis and preliminary biological evaluation of indole-3-carboxylic acid-based skeleton of Bcl-2\/Mcl-1 dual inhibitors. Bioorg Med Chem 2017,25(6),1939-1948","journal-title":"Bioorg Med Chem"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"5548","DOI":"10.1016\/j.bmc.2017.08.024","volume":"25","author":"Xu G.","year":"2017","unstructured":"Xu G.; Liu T.; Zhou Y.; Yang X.; Fang H.; 1-Phenyl-1H-indole derivatives as a new class of Bcl-2\/Mcl-1 dual inhibitors: Design, synthesis, and preliminary biological evaluation. Bioorg Med Chem 2017,25(20),5548-5556","journal-title":"Bioorg Med Chem"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13065-020-00675-5","volume":"14","author":"Shaker A.M.","year":"2020","unstructured":"Shaker A.M.; Abdelall E.K.; Abdellatif K.R.; Abdel-Rahman H.M.; Synthesis and biological evaluation of 2-(4-methylsulfonyl phenyl) indole derivatives: Multi-target compounds with dual antimicrobial and anti-inflammatory activities. BMC Chem 2020,14(1),1-15","journal-title":"BMC Chem"},{"key":"ref=106","first-page":"2231","volume":"7","author":"Sharaf El-Din N.","year":"2017","unstructured":"Sharaf El-Din N.; Barseem A.M.; Synthesis and computational studies on indole sulfonamide derivatives a new class of anti breast cancer agents. Asian J Biochem Pharm Res 2017,7,2231-2560","journal-title":"Asian J Biochem Pharm Res"},{"key":"ref=107","first-page":"69","volume":"7","author":"Abdellatif K.R.","year":"2017","unstructured":"Abdellatif K.R.; Elsaady M.T.; Amin N.H.; Hefny A.A.; Design, synthesis and biological evaluation of some novel indole derivatives as selective COX-2 inhibitors. J Appl Pharm Sci 2017,7,69-77","journal-title":"J Appl Pharm Sci"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.ejmech.2017.03.010","volume":"131","author":"Devender N.","year":"2017","unstructured":"Devender N.; Gunjan S.; Tripathi R.; Tripathi R.P.; Synthesis and antiplasmodial activity of novel indoleamide derivatives bearing sulfonamide and triazole pharmacophores. Eur J Med Chem 2017,131,171-184","journal-title":"Eur J Med Chem"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.bmc.2017.11.023","volume":"26","author":"Zhou Q.","year":"2018","unstructured":"Zhou Q.; Zhu J.; Chen J.; Ji P.; Qiao C.; N-Arylsulfonylsubstituted-1H indole derivatives as small molecule dual inhibitors of signal transducer and activator of transcription 3 (STAT3) and tubulin. Bioorg Med Chem 2018,26(1),96-106","journal-title":"Bioorg Med Chem"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/j.bmc.2015.01.032","volume":"23","author":"Hayat F.","year":"2015","unstructured":"Hayat F.; Viswanath A.N.I.; Pae A.N.; Rhim H.; Park W-K.; Choo H-Y.P.; Synthesis and biological evaluation of 4-nitroindole derivatives as 5-HT2A receptor antagonists. Bioorg Med Chem 2015,23(6),1313-1320","journal-title":"Bioorg Med Chem"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"10307","DOI":"10.1021\/acs.jmedchem.0c00726","volume":"63","author":"Zhou J.","year":"2020","unstructured":"Zhou J.; Bie J.; Wang X.; Liu Q.; Li R.; Chen H.; Hu J.; Cao H.; Ji W.; Li Y.; Liu S.; Shen Z.; Xu B.; Discovery of N-arylsulfonyl-indole-2-carboxamide derivatives as potent, selective, and orally bioavailable fructose-1, 6-bisphosphatase inhibitors-design, synthesis, in vivo glucose lowering effects, and X-ray crystal complex analysis. J Med Chem 2020,63(18),10307-10329","journal-title":"J Med Chem"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.ejmech.2018.10.066","volume":"162","author":"Lai M-J.","year":"2019","unstructured":"Lai M-J.; Ojha R.; Lin M-H.; Liu Y-M.; Lee H-Y.; Lin T.E.; Hsu K-C.; Chang C-Y.; Chen M-C.; Nepali K.; Chang J-Y.; Liou J-P.; 1-Arylsulfonyl indoline-benzamides as a new antitubulin agents, with inhibition of histone deacetylase. Eur J Med Chem 2019,162,612-630","journal-title":"Eur J Med Chem"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3329\/bjp.v12i2.30872","volume":"12","author":"Manoharan D.","year":"2017","unstructured":"Manoharan D.; Kulanthai K.; Sadhasivam G.; Raji V.; Thayumanavan P.; Synthesis, characterization and evaluation of antidiabetic activity of novel indoline derivatives. Bangladesh J Pharmacol 2017,12(2),167-172","journal-title":"Bangladesh J Pharmacol"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1021\/acs.jmedchem.5b01660","volume":"59","author":"Pelz N.F.","year":"2016","unstructured":"Pelz N.F.; Bian Z.; Zhao B.; Shaw S.; Tarr J.C.; Belmar J.; Gregg C.; Camper D.V.; Goodwin C.M.; Arnold A.L.; Sensintaffar J.L.; Friberg A.; Rossanese O.W.; Lee T.; Olejniczak E.T.; Fesik S.W.; Discovery of 2-indole-acylsulfonamide myeloid cell leukemia 1 (Mcl-1) inhibitors using fragment-based methods. J Med Chem 2016,59(5),2054-2066","journal-title":"J Med Chem"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"112780","DOI":"10.1016\/j.ejmech.2020.112780","volume":"208","author":"Xu Y.","year":"2020","unstructured":"Xu Y.; Zhang X-J.; Li W-B.; Wang X-R.; Wang S.; Qiao X-P.; Chen S-W.; Design, synthesis and biological evaluation of indole-2-one derivatives as potent BRD4 inhibitors. Eur J Med Chem 2020,208,112780","journal-title":"Eur J Med Chem"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.ejmech.2016.01.030","volume":"110","author":"Eldehna W.M.","year":"2016","unstructured":"Eldehna W.M.; Fares M.; Ceruso M.; Ghabbour H.A.; Abou-Seri S.M.; Abdel-Aziz H.A.; Abou El Ella D.A.; Supuran C.T.; Amido\/ureidosubstituted benzenesulfonamides-isatin conjugates as low nanomolar\/subnanomolar inhibitors of the tumor-associated carbonic anhydrase isoform XII. Eur J Med Chem 2016,110,259-266","journal-title":"Eur J Med Chem"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.ejmech.2017.01.017","volume":"127","author":"Eldehna W.M.","year":"2017","unstructured":"Eldehna W.M.; Al-Ansary G.H.; Bua S.; Nocentini A.; Gratteri P.; Altoukhy A.; Ghabbour H.; Ahmed H.Y.; Supuran C.T.; Novel indolin-2-one-based sulfonamides as carbonic anhydrase inhibitors: Synthesis, in vitro biological evaluation against carbonic anhydrases isoforms I, II, IV and VII and molecular docking studies. Eur J Med Chem 2017,127,521-530","journal-title":"Eur J Med Chem"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"103635","DOI":"10.1016\/j.bioorg.2020.103635","volume":"96","author":"George R.F.","year":"2020","unstructured":"George R.F.; Bua S.; Supuran C.T.; Awadallah F.M.; Synthesis of some N-aroyl-2-oxindole benzenesulfonamide conjugates with carbonic anhydrase inhibitory activity. Bioorg Chem 2020,96,103635","journal-title":"Bioorg Chem"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"103514","DOI":"10.1016\/j.bioorg.2019.103514","volume":"95","author":"George R.F.","year":"2020","unstructured":"George R.F.; Said M.F.; Bua S.; Supuran C.T.; Synthesis and selective inhibitory effects of some 2-oxindole benzenesulfonamide conjugates on human carbonic anhydrase isoforms CA I, CA II, CA IX and CAXII. Bioorg Chem 2020,95,103514","journal-title":"Bioorg Chem"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"3714","DOI":"10.1016\/j.bmc.2017.05.029","volume":"25","author":"Karal\u0131 N.","year":"2017","unstructured":"Karal\u0131 N.; Akdemir A.; G&#xF6;kta&#x15F; F.; Elma P.E.; Angeli A.; K\u0131z\u0131l\u0131rmak M.; Supuran C.T.; Novel sulfonamide-containing 2-indolinones that selectively inhibit tumor-associated alpha carbonic anhydrases. Bioorg Med Chem 2017,25(14),3714-3718","journal-title":"Bioorg Med Chem"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"111768","DOI":"10.1016\/j.ejmech.2019.111768","volume":"184","author":"Abo-Ashour M.F.","year":"2019","unstructured":"Abo-Ashour M.F.; Eldehna W.M.; Nocentini A.; Bonardi A.; Bua S.; Ibrahim H.S.; Elaasser M.M.; Kry\u0161tof V.; Jorda R.; Gratteri P.; Abou-Seri S.M.; Supuran C.T.; 3-Hydrazinoisatin-based benzenesulfonamides as novel carbonic anhydrase inhibitors endowed with anticancer activity: Synthesis, in vitro biological evaluation and in silico insights. Eur J Med Chem 2019,184,111768","journal-title":"Eur J Med Chem"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1080\/14756366.2018.1564045","volume":"34","author":"Akdemir A.","year":"2019","unstructured":"Akdemir A.; Angeli A.; G&#xF6;kta&#x15F; F.; Eraslan Elma P.; Karal\u0131 N.; Supuran C.T.; Novel 2-indolinones containing a sulfonamide moiety as selective inhibitors of candida &#x3B2;-carbonic anhydrase enzyme. J Enzyme Inhib Med Chem 2019,34(1),528-531","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.ejmech.2018.10.068","volume":"162","author":"Eldehna W.M.","year":"2019","unstructured":"Eldehna W.M.; Abo-Ashour M.F.; Nocentini A.; El-Haggar R.S.; Bua S.; Bonardi A.; Al-Rashood S.T.; Hassan G.S.; Gratteri P.; Abdel-Aziz H.A.; Supuran C.T.; Enhancement of the tail hydrophobic interactions within the carbonic anhydrase IX active site via structural extension: Design and synthesis of novel N-substituted isatins-SLC-0111 hybrids as carbonic anhydrase inhibitors and antitumor agents. Eur J Med Chem 2019,162,147-160","journal-title":"Eur J Med Chem"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ejmech.2018.07.054","volume":"157","author":"Abo-Ashour M.F.","year":"2018","unstructured":"Abo-Ashour M.F.; Eldehna W.M.; Nocentini A.; Ibrahim H.S.; Bua S.; Abou-Seri S.M.; Supuran C.T.; Novel hydrazido benzenesulfonamides-isatin conjugates: Synthesis, carbonic anhydrase inhibitory activity and molecular modeling studies. Eur J Med Chem 2018,157,28-36","journal-title":"Eur J Med Chem"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"6493","DOI":"10.1039\/C5OB00688K","volume":"13","author":"G&#xFC;zel-Akdemir &#xD6;.","year":"2015","unstructured":"G&#xFC;zel-Akdemir &#xD6;.; Akdemir A.; Karal\u0131 N.; Supuran C.T.; Discovery of novel isatin-based sulfonamides with potent and selective inhibition of the tumor-associated carbonic anhydrase isoforms IX and XII. Org Biomol Chem 2015,13(23),6493-6499","journal-title":"Org Biomol Chem"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1080\/13543776.2016.1216545","volume":"26","author":"Hussaini S.M.A.","year":"2016","unstructured":"Hussaini S.M.A.; Therapeutic significance of quinolines: A patent review (2013-2015). Expert Opin Ther Pat 2016,26(10),1201-1221","journal-title":"Expert Opin Ther Pat"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"4876","DOI":"10.1021\/ol402312h","volume":"15","author":"Yan R.","year":"2013","unstructured":"Yan R.; Liu X.; Pan C.; Zhou X.; Li X.; Kang X.; Huang G.; Aerobic synthesis of substituted quinoline from aldehyde and aniline: Copper-catalyzed intermolecular C\u2013H active and C\u2013C formative cyclization. Org Lett 2013,15(18),4876-4879","journal-title":"Org Lett"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.bjbas.2017.07.005","volume":"6","author":"Mandewale M.C.","year":"2017","unstructured":"Mandewale M.C.; Patil U.C.; Shedge S.V.; Dappadwad U.R.; Yamgar R.S.; A review on quinoline hydrazone derivatives as a new class of potent antitubercular and anticancer agents. Beni Suef Univ J Basic Appl Sci 2017,6(4),354-361","journal-title":"Beni Suef Univ J Basic Appl Sci"},{"key":"ref=129","first-page":"446","volume":"20","author":"Hosseinzadeh H.","year":"2017","unstructured":"Hosseinzadeh H.; Mazaheri F.; Ghodsi R.; Pharmacological effects of a synthetic quinoline, a hybrid of tomoxiprole and naproxen, against acute pain and inflammation in mice: A behavioral and docking study. Iran J Basic Med Sci 2017,20(4),446","journal-title":"Iran J Basic Med Sci"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"4192","DOI":"10.1016\/j.ejmech.2011.06.022","volume":"46","author":"Mungra D.C.","year":"2011","unstructured":"Mungra D.C.; Patel M.P.; Rajani D.P.; Patel R.G.; Synthesis and identification of &#x3B2;-aryloxyquinolines and their pyrano [3, 2-c] chromene derivatives as a new class of antimicrobial and antituberculosis agents. Eur J Med Chem 2011,46(9),4192-4200","journal-title":"Eur J Med Chem"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.ejmech.2013.08.048","volume":"69","author":"Al-Dosari M.S.","year":"2013","unstructured":"Al-Dosari M.S.; Ghorab M.M.; AlSaid M.S.; Nissan Y.M.; Ahmed A.B.; Synthesis and anticancer activity of some novel trifluoromethylquinolines carrying a biologically active benzenesulfonamide moiety. Eur J Med Chem 2013,69,373-383","journal-title":"Eur J Med Chem"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1080\/00387010.2017.1383920","volume":"50","author":"Marciniec K.","year":"2017","unstructured":"Marciniec K.; Pawe\u0142czak B.; Latocha M.; Su\u0142kowski L.; Ma&#x15B;lankiewicz A.; Maci\u0105&#x17C;ek-Jurczyk M.; Boryczka S.; Quinolinesulfonamides: Interaction between bovine serum albumin, molecular docking analysis, and antiproliferative activity against human breast carcinoma cells. Spectrosc Lett 2017,50(10),532-538","journal-title":"Spectrosc Lett"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1248\/cpb.c12-00812","volume":"61","author":"Al-Dosari M.S.","year":"2013","unstructured":"Al-Dosari M.S.; Ghorab M.M.; Al-Said M.S.; Nissan Y.M.; Discovering some novel 7-chloroquinolines carrying a biologically active benzenesulfonamide moiety as a new class of anticancer agents. Chem Pharm Bull (Tokyo) 2013,61(1),50-58","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00894-019-4091-7","volume":"25","author":"Moreira C.","year":"2019","unstructured":"Moreira C.; Cust&#xF3;dio J.; Vaz W.; D\u2019Oliveira G.; Perez C.N.; Napolitano H.; A comprehensive study on crystal structure of a novel sulfonamide-dihydroquinolinone through experimental and theoretical approaches. J Mol Model 2019,25(7),1-10","journal-title":"J Mol Model"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"3161","DOI":"10.4155\/fmc-2019-0106","volume":"11","author":"Swetha R.","year":"2019","unstructured":"Swetha R.; Kumar D.; Gupta S.K.; Ganeshpurkar A.; Singh R.; Gutti G.; Kumar D.; Jana S.; Krishnamurthy S.; Singh S.K.; Multifunctional hybrid sulfonamides as novel therapeutic agents for Alzheimer\u2019s disease. Future Med Chem 2019,11(24),3161-3178","journal-title":"Future Med Chem"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"5691","DOI":"10.1007\/s11164-017-2956-x","volume":"43","author":"Kumar L.J.","year":"2017","unstructured":"Kumar L.J.; Vijayakumar V.; A new class of arylsulfonamide-based 3-acetyl-2-methyl-4-phenylquinolines and in vitro evaluation of their antioxidant, antifungal, and antibacterial activities. Res Chem Intermed 2017,43(10),5691-5705","journal-title":"Res Chem Intermed"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"5979","DOI":"10.1016\/j.bmc.2015.06.056","volume":"23","author":"Pinheiro L.C.","year":"2015","unstructured":"Pinheiro L.C.; Boechat N.; Maria de Lourdes G.F.; J&#xFA;nior C.C.; Jesus A.M.; Leite M.M.; Souza N.B.; Krettli A.U.; Anti-Plasmodium falciparum activity of quinoline-sulfonamide hybrids. Bioorg Med Chem 2015,23(17),5979-5984","journal-title":"Bioorg Med Chem"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1007\/s00044-017-1850-9","volume":"26","author":"Ahmed N.","year":"2017","unstructured":"Ahmed N.; Badahdah K.; Qassar H.; Novel quinoline bearing sulfonamide derivatives and their cytotoxic activity against MCF7 cell line. Med Chem Res 2017,26(6),1201-1212","journal-title":"Med Chem Res"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1080\/14756366.2019.1626376","volume":"34","author":"Thacker P.S.","year":"2019","unstructured":"Thacker P.S.; Shaikh P.; Angeli A.; Arifuddin M.; Supuran C.T.; Synthesis and biological evaluation of novel 8-substituted quinoline-2-carboxamides as carbonic anhydrase inhibitors. J Enzyme Inhib Med Chem 2019,34(1),1172-1177","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.bmc.2014.12.060","volume":"23","author":"Singh S.","year":"2015","unstructured":"Singh S.; Roy K.K.; Khan S.R.; Kashyap V.K.; Sharma A.; Jaiswal S.; Sharma S.K.; Krishnan M.Y.; Chaturvedi V.; Lal J.; Sinha S.; Dasgupta A.; Srivastava R.; Saxena A.K.; Novel, potent, orally bioavailable and selective mycobacterial ATP synthase inhibitors that demonstrated activity against both replicating and non-replicating M. tuberculosis. Bioorg Med Chem 2015,23(4),742-752","journal-title":"Bioorg Med Chem"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.ejmech.2017.08.052","volume":"139","author":"Bano B.","year":"2017","unstructured":"Bano B.; Khan K.M.; Fatima B.; Taha M.; Ismail N.H.; Wadood A.; Ghufran M.; Perveen S.; Synthesis, in vitro &#x3B2;-glucuronidase inhibitory potential and molecular docking studies of quinolines. Eur J Med Chem 2017,139,849-864","journal-title":"Eur J Med Chem"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1002\/jhet.3849","volume":"57","author":"El\u2010Mekabaty A.","year":"2020","unstructured":"El\u2010Mekabaty A.; Awad H.M.; Convenient synthesis of novel sulfonamide derivatives as promising anticancer agents. J Heterocycl Chem 2020,57(3),1123-1132","journal-title":"J Heterocycl Chem"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1007\/s00044-019-02384-8","volume":"28","author":"d\u2019Oliveira G.D.","year":"2019","unstructured":"d\u2019Oliveira G.D.; Custodio J.M.; Moura A.F.; Napolitano H.B.; P&#xE9;rez C.N.; Moraes M.O.; Pr&#xF3;kai L.; Perj&#xE9;si P.; Different reactivity to glutathione but similar tumor cell toxicity of chalcones and their quinolinone analogues. Med Chem Res 2019,28(9),1448-1460","journal-title":"Med Chem Res"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"115525","DOI":"10.1016\/j.bmc.2020.115525","volume":"28","author":"Al-Sanea M.M.","year":"2020","unstructured":"Al-Sanea M.M.; Elkamhawy A.; Paik S.; Lee K.; El Kerdawy A.M.; Abbas B.S.N.; Roh E.J.; Eldehna W.M.; Elshemy H.A.; Bakr R.B.; Sulfonamide-based 4-anilinoquinoline derivatives as novel dual Aurora kinase (AURKA\/B) inhibitors: Synthesis, biological evaluation and in silico insights. Bioorg Med Chem 2020,28(13),115525","journal-title":"Bioorg Med Chem"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1080\/14756366.2019.1652282","volume":"34","author":"Al-Sanea M.M.","year":"2019","unstructured":"Al-Sanea M.M.; Elkamhawy A.; Paik S.; Bua S.; Lee H.S.; Abdelgawad M.A.; Roh E.J.; Eldehna W.M.; Supuran C.T.; Synthesis and biological evaluation of novel 3-(quinolin-4-ylamino) benzenesulfonamides as carbonic anhydrase isoforms I and II inhibitors. J Enzyme Inhib Med Chem 2019,34(1),1457-1464","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1002\/jhet.3448","volume":"56","author":"Hekal M.H.","year":"2019","unstructured":"Hekal M.H.; Abu El\u2010Azm F.S.; Sallam H.A.; Synthesis, spectral characterization, and in vitro biological evaluation of some novel isoquinolinone\u2010based heterocycles as potential antitumor agents. J Heterocycl Chem 2019,56(3),795-803","journal-title":"J Heterocycl Chem"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s12551-015-0183-5","volume":"7","author":"Khan A.Y.","year":"2015","unstructured":"Khan A.Y.; Kumar G.S.; Natural isoquinoline alkaloids: Binding aspects to functional proteins, serum albumins, hemoglobin, and lysozyme. Biophys Rev 2015,7(4),407-420","journal-title":"Biophys Rev"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1002\/cmdc.201500596","volume":"11","author":"Bruno E.","year":"2016","unstructured":"Bruno E.; Buemi M.R.; De Luca L.; Ferro S.; Monforte A.M.; Supuran C.T.; Vullo D.; De Sarro G.; Russo E.; Gitto R.; In vivo evaluation of selective carbonic anhydrase inhibitors as potential anticonvulsant agents. ChemMedChem 2016,11(16),1812-1818","journal-title":"ChemMedChem"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1080\/14756366.2018.1490732","volume":"33","author":"Oliveira R.G.","year":"2018","unstructured":"Oliveira R.G.; Guerra F.S.; Mermelstein C.S.; Fernandes P.D.; Bastos I.T.S.; Costa F.N.; Barroso R.C.R.; Ferreira F.F.; Fraga C.A.M.; Synthesis and pharmacological evaluation of novel isoquinoline N-sulphonylhydrazones designed as ROCK inhibitors. J Enzyme Inhib Med Chem 2018,33(1),1181-1193","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=150","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2298\/JSC200802076M","volume":"86","author":"Manolov S.P.","year":"2020","unstructured":"Manolov S.P.; Ivanov I.I.; Bojilov D.G.; Microwave-assisted synthesis of 1, 2, 3, 4-tetrahydroisoquinoline sulfonamide derivatives and their biological evaluation. J Serb Chem Soc 2020,86(00),139-151","journal-title":"J Serb Chem Soc"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"8631","DOI":"10.1021\/acs.jmedchem.9b01003","volume":"62","author":"Prchalov&#xE1; E.","year":"2019","unstructured":"Prchalov&#xE1; E.; Hin N.; Thomas A.G.; Veeravalli V.; Ng J.; Alt J.; Rais R.; Rojas C.; Li Z.; Hihara H.; Aoki M.; Yoshizawa K.; Nishioka T.; Suzuki S.; Kopajtic T.; Chatrath S.; Liu Q.; Dong X.; Slusher B.S.; Tsukamoto T.; Discovery of benzamidine-and 1-aminoisoquinoline-based human MAS-related G-protein-coupled receptor X1 (MRGPRX1) agonists. J Med Chem 2019,62(18),8631-8641","journal-title":"J Med Chem"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"4316","DOI":"10.1021\/acs.jmedchem.7b00264","volume":"60","author":"Bruno E.","year":"2017","unstructured":"Bruno E.; Buemi M.R.; Di Fiore A.; De Luca L.; Ferro S.; Angeli A.; Cirilli R.; Sadutto D.; Alterio V.; Monti S.M.; Supuran C.T.; De Simone G.; Gitto R.; Probing molecular interactions between human carbonic anhydrases (hCAs) and a novel class of benzenesulfonamides. J Med Chem 2017,60(10),4316-4326","journal-title":"J Med Chem"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.ejmech.2015.07.049","volume":"102","author":"Buemi M.R.","year":"2015","unstructured":"Buemi M.R.; De Luca L.; Ferro S.; Bruno E.; Ceruso M.; Supuran C.T.; Posp&#xED;\u0161ilov&#xE1; K.; Brynda J.; \u0158ez&#xE1;&#x10D;ov&#xE1; P.; Gitto R.; Carbonic anhydrase inhibitors: Design, synthesis and structural characterization of new heteroaryl-N-carbonylbenzenesulfonamides targeting druggable human carbonic anhydrase isoforms. Eur J Med Chem 2015,102,223-232","journal-title":"Eur J Med Chem"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ejmech.2006.09.019","volume":"42","author":"Nowakowska Z.","year":"2007","unstructured":"Nowakowska Z.; A review of anti-infective and anti-inflammatory chalcones. Eur J Med Chem 2007,42(2),125-137","journal-title":"Eur J Med Chem"},{"key":"ref=155","first-page":"130","volume":"140","author":"Bo&#x17E;i\u0107 D.D.","year":"2014","unstructured":"Bo&#x17E;i\u0107 D.D.; Milenkovi\u0107 M.; Ivkovi\u0107 B.; Cirkovi\u0107 I.; Antibacterial activity of three newly-synthesized chalcones","journal-title":"Indian J Med Res"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.bioorg.2019.03.033","volume":"87","year":"2019","unstructured":"ur Rashid, H.; Xu, Y.; Ahmad, N.; Muhammad, Y.; Wang, L. Promising anti-inflammatory effects of chalcones via inhibition of cyclooxygenase, prostaglandin E2, inducible NO synthase and nuclear factor &#x3BA;b activities. Bioorg Chem 2019,87,335-365","journal-title":"Bioorg Chem"},{"key":"ref=157","doi-asserted-by":"publisher","first-page":"112215","DOI":"10.1016\/j.ejmech.2020.112215","volume":"193","author":"Qin H-L.","year":"2020","unstructured":"Qin H-L.; Zhang Z-W.; Lekkala R.; Alsulami H.; Rakesh K.; Chalcone hybrids as privileged scaffolds in antimalarial drug discovery: A key review. Eur J Med Chem 2020,193,112215","journal-title":"Eur J Med Chem"},{"key":"ref=158","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s00044-018-02283-4","volume":"28","author":"Mu\u0161kinja J.M.","year":"2019","unstructured":"Mu\u0161kinja J.M.; Burmud&#x17E;ija A.Z.; Baski\u0107 D.D.; Popovi\u0107 S.L.; Todorovi\u0107 D.V.; Zari\u0107 M.M.; Ratkovi\u0107 Z.R.; Synthesis and anticancer activity of chalcone analogues with sulfonyl groups. Med Chem Res 2019,28(3),279-291","journal-title":"Med Chem Res"},{"key":"ref=159","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1080\/13543776.2019.1613374","volume":"29","author":"Kar Mahapatra D.","year":"2019","unstructured":"Kar Mahapatra D.; Asati V.; Bharti S.K.; An updated patent review of therapeutic applications of chalcone derivatives (2014-present). Expert Opin Ther Pat 2019,29(5),385-406","journal-title":"Expert Opin Ther Pat"},{"key":"ref=160","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s12291-017-0727-5","volume":"34","author":"Bhoj P.","year":"2019","unstructured":"Bhoj P.; Togre N.; Bahekar S.; Goswami K.; Chandak H.; Patil M.; Immunomodulatory activity of sulfonamide chalcone compounds in mice infected with filarial parasite, Brugia malayi. Indian J Clin Biochem 2019,34(2),225-229","journal-title":"Indian J Clin Biochem"},{"key":"ref=161","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.farmac.2005.01.005","volume":"60","author":"Dom&#xED;nguez J.N.","year":"2005","unstructured":"Dom&#xED;nguez J.N.; Le&#xF3;n C.; Rodrigues J.; de Dom&#xED;nguez N.G.; Gut J.; Rosenthal P.J.; Synthesis and antimalarial activity of sulfonamide chalcone derivatives. Farmaco 2005,60(4),307-311","journal-title":"Farmaco"},{"key":"ref=162","doi-asserted-by":"publisher","first-page":"3426","DOI":"10.1039\/C7NJ03523C","volume":"42","author":"Custodio J.M.","year":"2018","unstructured":"Custodio J.M.; Michelini L.J.; de Castro M.R.C.; Vaz W.F.; Neves B.J.; Cravo P.V.; Barreto F.S.; Manoel Filho O.; Perez C.N.; Napolitano H.B.; Structural insights into a novel anticancer sulfonamide chalcone. New J Chem 2018,42(5),3426-3434","journal-title":"New J Chem"},{"key":"ref=163","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ejmech.2019.05.013","volume":"176","author":"Casta&#xF1;o L.F.","year":"2019","unstructured":"Casta&#xF1;o L.F.; Cuartas V.; Bernal A.; Insuasty A.; Guzman J.; Vidal O.; Rubio V.; Puerto G.; Luk&#xE1;&#x10D; P.; Vimberg V.; Bal&#xED;kov&#xE1;-Novton&#xE1; G.; Vannucci L.; Janata J.; Quiroga J.; Abonia R.; Nogueras M.; Cobo J.; Insuasty B.; New chalcone-sulfonamide hybrids exhibiting anticancer and antituberculosis activity. Eur J Med Chem 2019,176,50-60","journal-title":"Eur J Med Chem"},{"key":"ref=164","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.ejmech.2015.01.036","volume":"92","author":"Ghorab M.M.","year":"2015","unstructured":"Ghorab M.M.; Ragab F.A.; Heiba H.I.; El-Gazzar M.G.; Zahran S.S.; Synthesis, anticancer and radiosensitizing evaluation of some novel sulfonamide derivatives. Eur J Med Chem 2015,92,682-692","journal-title":"Eur J Med Chem"},{"key":"ref=165","first-page":"565","volume":"16","author":"Bonakdar A.P.S.","year":"2017","unstructured":"Bonakdar A.P.S.; Vafaei F.; Farokhpour M.; Esfahani M.H.N.; Massah A.R.; Synthesis and anticancer activity assay of novel chalcone-sulfonamide derivatives. Iran J Pharm Res 2017,16(2),565","journal-title":"Iran J Pharm Res"},{"key":"ref=166","first-page":"35","volume":"9","author":"Arshad M.","year":"2018","unstructured":"Arshad M.; 4-[(1E)-3-(Substituted-phenyl)-3-oxoprop-1-en-1-yl] benzenesulfonamide: Design, computational, synthesis, characterization and antibacterial assessment. Int J Pharm Sci Res 2018,9,35-41","journal-title":"Int J Pharm Sci Res"},{"key":"ref=167","first-page":"179","volume":"147","author":"Meena L.R.","year":"2020","unstructured":"Meena L.R.; Sharma V.S.; Swarnkar P.; Synthesis, biological investigations, QSAR and DFT analysis of sulfonamide chalcones as potential: Antimicrobial, antifungal and antimalarial agents. World Sci News 2020,147,179-196","journal-title":"World Sci News"},{"key":"ref=168","doi-asserted-by":"publisher","first-page":"3294","DOI":"10.1039\/C9NJ05612B","volume":"44","author":"Custodio J.M.","year":"2020","unstructured":"Custodio J.M.; Moura A.F.; de Moraes M.O.; Perez C.N.; Napolitano H.B.; On the in silico and in vitro anticancer activity of sulfonamide chalcones: Potential JNKK3 inhibitors. New J Chem 2020,44(8),3294-3309","journal-title":"New J Chem"},{"key":"ref=169","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s00706-020-02568-8","volume":"151","author":"Mustafa M.","year":"2020","unstructured":"Mustafa M.; Mostafa Y.A.; A facile synthesis, drug-likeness, and in silico molecular docking of certain new azidosulfonamide\u2013chalcones and their in vitro antimicrobial activity. Monatsh Chem 2020,151(3),417-427","journal-title":"Monatsh Chem"},{"key":"ref=170","first-page":"85","volume":"63","author":"Khanusiya M.","year":"2019","unstructured":"Khanusiya M.; Gadhawala Z.; Chalcones-sulphonamide hybrids: Synthesis, characterization and anticancer evaluation. J Korean Chem Soc 2019,63(2),85-93","journal-title":"J Korean Chem Soc"},{"key":"ref=171","doi-asserted-by":"publisher","first-page":"5867","DOI":"10.1016\/j.bmcl.2016.11.017","volume":"26","author":"Arslan T.","year":"2016","unstructured":"Arslan T.; T&#xFC;rko&#x11F;lu E.A.; &#x15E;ent&#xFC;rk M.; Supuran C.T.; Synthesis and carbonic anhydrase inhibitory properties of novel chalcone substituted benzenesulfonamides. Bioorg Med Chem Lett 2016,26(24),5867-5870","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=172","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.ejmech.2016.08.042","volume":"124","author":"Bahekar S.P.","year":"2016","unstructured":"Bahekar S.P.; Hande S.V.; Agrawal N.R.; Chandak H.S.; Bhoj P.S.; Goswami K.; Reddy M.; Sulfonamide chalcones: Synthesis and in vitro exploration for therapeutic potential against Brugia malayi. Eur J Med Chem 2016,124,262-269","journal-title":"Eur J Med Chem"},{"key":"ref=173","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3390\/molecules23010134","volume":"23","author":"Karrouchi K.","year":"2018","unstructured":"Karrouchi K.; Radi S.; Ramli Y.; Taoufik J.; Mabkhot Y.N.; Al-Aizari F.A.; Ansar M.; Synthesis and pharmacological activities of pyrazole derivatives: A review. Molecules 2018,23(1),134","journal-title":"Molecules"},{"key":"ref=174","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.ejmech.2016.09.071","volume":"125","author":"Ahn M.","year":"2017","unstructured":"Ahn M.; Gunasekaran P.; Rajasekaran G.; Kim E.Y.; Lee S-J.; Bang G.; Cho K.; Hyun J-K.; Lee H-J.; Jeon Y.H.; Kim N-H.; Ryu E.K.; Shin S.Y.; Bang J.K.; Pyrazole derived ultra-short antimicrobial peptidomimetics with potent anti-biofilm activity. Eur J Med Chem 2017,125,551-564","journal-title":"Eur J Med Chem"},{"key":"ref=175","doi-asserted-by":"publisher","first-page":"5799","DOI":"10.1016\/j.bmc.2015.07.010","volume":"23","author":"Nitulescu G.M.","year":"2015","unstructured":"Nitulescu G.M.; Draghici C.; Olaru O.T.; Matei L.; Ioana A.; Dragu L.D.; Bleotu C.; Synthesis and apoptotic activity of new pyrazole derivatives in cancer cell lines. Bioorg Med Chem 2015,23(17),5799-5808","journal-title":"Bioorg Med Chem"},{"key":"ref=176","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.bioorg.2018.03.027","volume":"78","author":"Gul H.I.","year":"2018","unstructured":"Gul H.I.; Yamali C.; Bulbuller M.; Kirmizibayrak P.B.; Gul M.; Angeli A.; Bua S.; Supuran C.T.; Anticancer effects of new dibenzenesulfonamides by inducing apoptosis and autophagy pathways and their carbonic anhydrase inhibitory effects on hCA I, hCA II, hCA IX, hCA XII isoenzymes. Bioorg Chem 2018,78,290-297","journal-title":"Bioorg Chem"},{"key":"ref=177","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1007\/s00044-011-9691-4","volume":"21","author":"El-Moghazy S.M.","year":"2012","unstructured":"El-Moghazy S.M.; Barsoum F.F.; Abdel-Rahman H.M.; Marzouk A.A.; Synthesis and anti-inflammatory activity of some pyrazole derivatives. Med Chem Res 2012,21(8),1722-1733","journal-title":"Med Chem Res"},{"key":"ref=178","doi-asserted-by":"publisher","first-page":"183","DOI":"10.4155\/fmc-2017-0144","volume":"10","author":"Eid N.M.","year":"2018","unstructured":"Eid N.M.; George R.F.; Facile synthesis of some pyrazoline-based compounds with promising anti-inflammatory activity. Future Med Chem 2018,10(02),183-199","journal-title":"Future Med Chem"},{"key":"ref=179","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.bioorg.2017.08.014","volume":"74","author":"Abdelgawad M.A.","year":"2017","unstructured":"Abdelgawad M.A.; Labib M.B.; Abdel-Latif M.; Pyrazole-hydrazone derivatives as anti-inflammatory agents: Design, synthesis, biological evaluation, COX-1, 2\/5-LOX inhibition and docking study. Bioorg Chem 2017,74,212-220","journal-title":"Bioorg Chem"},{"key":"ref=180","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.bioorg.2016.12.008","volume":"70","author":"Alsayed S.S.","year":"2017","unstructured":"Alsayed S.S.; Elshemy H.A.; Abdelgawad M.A.; Abdel-Latif M.S.; Abdellatif K.R.; Design, synthesis and biological screening of some novel celecoxib and etoricoxib analogs with promising COX-2 selectivity, anti-inflammatory activity and gastric safety profile. Bioorg Chem 2017,70,173-183","journal-title":"Bioorg Chem"},{"key":"ref=181","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/670181","volume":"2015","author":"Datar P.A.","year":"2015","unstructured":"Datar P.A.; Jadhav S.R.; Design and synthesis of pyrazole-3-one derivatives as hypoglycaemic agents. Int J Med Chem 2015,2015,1-10","journal-title":"Int J Med Chem"},{"key":"ref=182","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s10787-016-0270-7","volume":"24","author":"Domiati S.","year":"2016","unstructured":"Domiati S.; El-Mallah A.; Ghoneim A.; Bekhit A.; Abd El Razik H.; Evaluation of anti-inflammatory, analgesic activities, and side effects of some pyrazole derivatives. Inflammopharmacology 2016,24(4),163-172","journal-title":"Inflammopharmacology"},{"key":"ref=183","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1134\/S1068162020030048","volume":"46","author":"Bonakdar A.","year":"2020","unstructured":"Bonakdar A.; Sadeghi A.; Aghaei H.; Beheshtimaal K.; Nazifi S.; Massah A.; Convenient synthesis of novel chalcone and pyrazoline sulfonamide derivatives as potential antibacterial agents. Russ J Bioorganic Chem 2020,46(3),371-381","journal-title":"Russ J Bioorganic Chem"},{"key":"ref=184","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1080\/14756366.2016.1217852","volume":"31","author":"Kucukoglu K.","year":"2016","unstructured":"Kucukoglu K.; Oral F.; Aydin T.; Yamali C.; Algul O.; Sakagami H.; Gulcin I.; Supuran C.T.; Gul H.I.; Synthesis, cytotoxicity and carbonic anhydrase inhibitory activities of new pyrazolines. J Enzyme Inhib Med Chem 2016,31(sup4),20-24","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=185","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12039-020-01792-3","volume":"132","author":"Chalkha M.","year":"2020","unstructured":"Chalkha M.; Bakhouch M.; Akhazzane M.; Bourass M.; Nicolas Y.; Al Houari G.; El Yazidi M.; Design, synthesis and characterization of functionalized pyrazole derivatives bearing amide and sulfonamide moieties from aza-aurones. J Chem Sci 2020,132(1),1-8","journal-title":"J Chem Sci"},{"key":"ref=186","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s12088-017-0689-6","volume":"58","author":"Badgujar J.R.","year":"2018","unstructured":"Badgujar J.R.; More D.H.; Meshram J.S.; Synthesis, antimicrobial and antioxidant activity of pyrazole based sulfonamide derivatives. Indian J Microbiol 2018,58(1),93-99","journal-title":"Indian J Microbiol"},{"key":"ref=187","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1002\/jhet.3118","volume":"55","author":"Pavase L.S.","year":"2018","unstructured":"Pavase L.S.; Mane D.V.; Baheti K.G.; Anti\u2010inflammatory exploration of sulfonamide containing diaryl pyrazoles with promising COX\u20102 selectivity and enhanced gastric safety profile. J Heterocycl Chem 2018,55(4),913-922","journal-title":"J Heterocycl Chem"},{"key":"ref=188","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1016\/j.arabjc.2015.05.020","volume":"12","author":"Mert S.","year":"2019","unstructured":"Mert S.; Al\u0131m Z.; \u0130&#x15F;g&#xF6;r M.M.; An\u0131l B.; Kas\u0131mo&#x11F;ullar\u0131 R.; Beydemir &#x15E;.; Novel pyrazole-3, 4-dicarboxamides bearing biologically active sulfonamide moiety as potential carbonic anhydrase inhibitors. Arab J Chem 2019,12(8),2740-2748","journal-title":"Arab J Chem"},{"key":"ref=189","doi-asserted-by":"publisher","first-page":"103222","DOI":"10.1016\/j.bioorg.2019.103222","volume":"92","author":"Yamali C.","year":"2019","unstructured":"Yamali C.; Gul H.I.; Ece A.; Bua S.; Angeli A.; Sakagami H.; Sahin E.; Supuran C.T.; Synthesis, biological evaluation and in silico modelling studies of 1, 3, 5-trisubstituted pyrazoles carrying benzenesulfonamide as potential anticancer agents and selective cancer-associated hCA IX isoenzyme inhibitors. Bioorg Chem 2019,92,103222","journal-title":"Bioorg Chem"},{"key":"ref=190","first-page":"4414","volume":"11","author":"Najm R.S.","year":"2019","unstructured":"Najm R.S.; Synthesis and biological activity evaluation of some new pyrazole derivatives. Int J Pharm Res 2019,11(1),4414-4421","journal-title":"Int J Pharm Res"},{"key":"ref=191","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.2174\/1389557518666180530124509","volume":"18","author":"Abdel Hafez N.A.","year":"2018","unstructured":"Abdel Hafez N.A.; Ali K.A.; Ibrahim A.A.; Elnaggar D.H.; Sleem A.A.; Design, synthesis and in-vivo anti-inflammatory activity of new celecoxib analogues as NSAID. Mini Rev Med Chem 2018,18(16),1398-1408","journal-title":"Mini Rev Med Chem"},{"key":"ref=192","doi-asserted-by":"publisher","first-page":"6393428","DOI":"10.1155\/2020\/6393428","volume":"2020","author":"Assali M.","year":"2020","unstructured":"Assali M.; Abualhasan M.; Sawaftah H.; Hawash M.; Mousa A.; Synthesis, biological activity, and molecular modeling studies of pyrazole and triazole derivatives as selective COX-2 inhibitors. J Chem 2020,2020,6393428","journal-title":"J Chem"},{"key":"ref=193","doi-asserted-by":"publisher","first-page":"103878","DOI":"10.1016\/j.bioorg.2020.103878","volume":"100","author":"Ibrahim T.S.","year":"2020","unstructured":"Ibrahim T.S.; Salem I.M.; Mostafa S.M.; El-Sabbagh O.I.; ElKhamisi M.K.; Hegazy L.; Elgendy B.; Design, synthesis, and pharmacological evaluation of novel and selective COX-2 inhibitors based on bumetanide scaffold. Bioorg Chem 2020,100,103878","journal-title":"Bioorg Chem"},{"key":"ref=194","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3184\/174751916X14552786665833","volume":"40","author":"Mustafa G.","year":"2016","unstructured":"Mustafa G.; Zia-ur-Rehman, M.; Khan, I.U.; Ishtiaq, S.; Hussain, S.; Arshad, M.N.; Asiri, A.M. Novel 4-[5-{4-[(2-benzylidenehydrazine) carbonyl] phenyl}-3-(trifluoromethyl)-1 H-pyrazol-1-yl] benzenesulfonamides: Synthesis, crystal structure, anti-Inflammatory and ulcerogenecity studies. J Chem Res 2016,40(3),167-172","journal-title":"J Chem Res"},{"key":"ref=195","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s00044-017-2035-2","volume":"27","author":"El-Gaby M.S.","year":"2018","unstructured":"El-Gaby M.S.; Ghorab M.M.; Ismail Z.H.; Abdel-Gawad S.M.; Aly H.M.; Synthesis, structural characterization and anticancer evaluation of pyrazole derivatives. Med Chem Res 2018,27(1),72-79","journal-title":"Med Chem Res"},{"key":"ref=196","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s00706-015-1549-x","volume":"147","author":"Ashour H.M.","year":"2016","unstructured":"Ashour H.M.; El-Ashmawy I.M.; Bayad A.E.; Synthesis and pharmacological evaluation of new pyrazolyl benzenesulfonamides linked to polysubstituted pyrazoles and thiazolidinones as anti-inflammatory and analgesic agents. Monatsh Chem 2016,147(3),605-618","journal-title":"Monatsh Chem"},{"key":"ref=197","doi-asserted-by":"publisher","first-page":"3529","DOI":"10.2147\/DDDT.S118297","volume":"10","author":"Alam M.J.","year":"2016","unstructured":"Alam M.J.; Alam O.; Khan S.A.; Naim M.J.; Islamuddin M.; Deora G.S.; Synthesis, anti-inflammatory, analgesic, COX1\/2-inhibitory activity, and molecular docking studies of hybrid pyrazole analogues. Drug Des Devel Ther 2016,10,3529-3543","journal-title":"Drug Des Devel Ther"},{"key":"ref=198","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s11164-016-2620-x","volume":"43","author":"Duan X.","year":"2017","unstructured":"Duan X.; Wang Y.; Feng W.; Yang Y.; Li H.; Li S.; Yang X.; Zhang J.; Wang S.; Zhou G.; Zhou C.; Design, synthesis and biological evaluation of some novel N-arylpyrazole derivatives bearing the sulfonamide moiety as cytotoxic agents. Res Chem Intermed 2017,43(1),271-281","journal-title":"Res Chem Intermed"},{"key":"ref=199","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1007\/s00044-017-1957-z","volume":"26","author":"Gong Z-H.","year":"2017","unstructured":"Gong Z-H.; Yao J.; Ji J-F.; Yang J.; Xiang T.; Zhou C-K.; Synthesis and biological evaluation of novel N-(5-phenyl-1 H-pyrazol-3-yl) benzenesulfonamide derivatives as potential BRAF V600E inhibitors. Med Chem Res 2017,26(10),2583-2591","journal-title":"Med Chem Res"},{"key":"ref=200","doi-asserted-by":"publisher","first-page":"3208","DOI":"10.1016\/j.bmcl.2015.05.096","volume":"25","author":"Khloya P.","year":"2015","unstructured":"Khloya P.; Ceruso M.; Ram S.; Supuran C.T.; Sharma P.K.; Sulfonamide bearing pyrazolylpyrazolines as potent inhibitors of carbonic anhydrase isoforms I, II, IX and XII. Bioorg Med Chem Lett 2015,25(16),3208-3212","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=201","doi-asserted-by":"publisher","first-page":"112662","DOI":"10.1016\/j.ejmech.2020.112662","volume":"205","author":"Abdelazeem A.H.","year":"2020","unstructured":"Abdelazeem A.H.; El-Din A.G.S.; Abdel-Fattah M.M.; Amin N.H.; El-Moghazy S.M.; El-Saadi M.T.; Discovery of novel urea-diarylpyrazole hybrids as dual COX-2\/sEH inhibitors with improved anti-inflammatory activity and highly reduced cardiovascular risks. Eur J Med Chem 2020,205,112662","journal-title":"Eur J Med Chem"},{"key":"ref=202","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1007\/s11030-020-10121-2","volume":"25","author":"Ngo Q.A.","year":"2021","unstructured":"Ngo Q.A.; Thi T.H.N.; Pham M.Q.; Delfino D.; Do T.T.; Antiproliferative and antiinflammatory coxib\u2013combreta-statin hybrids suppress cell cycle progression and induce apoptosis of MCF7 breast cancer cells. Mol Divers 2021,25(4),2307-2319","journal-title":"Mol Divers"},{"key":"ref=203","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.ejmech.2019.03.042","volume":"171","author":"Taher E.S.","year":"2019","unstructured":"Taher E.S.; Ibrahim T.S.; Fares M.; Al-Mahmoudy A.M.; Radwan A.F.; Orabi K.Y.; El-Sabbagh O.I.; Novel benzenesulfonamide and 1, 2-benzisothiazol-3 (2H)-one-1, 1-dioxide derivatives as potential selective COX-2 inhibitors. Eur J Med Chem 2019,171,372-382","journal-title":"Eur J Med Chem"},{"key":"ref=204","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1080\/14756366.2017.1344236","volume":"32","author":"Krasavin M.","year":"2017","unstructured":"Krasavin M.; Korsakov M.; Ronzhina O.; Tuccinardi T.; Kalinin S.; Tan&#xE7; M.; Supuran C.T.; Primary mono-and bis-sulfonamides obtained via regiospecific sulfochlorination of N-arylpyrazoles: Inhibition profile against a panel of human carbonic anhydrases. J Enzyme Inhib Med Chem 2017,32(1),920-934","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=205","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1007\/s00706-016-1694-x","volume":"147","author":"Somakala K.","year":"2016","unstructured":"Somakala K.; Amir M.; Sharma V.; Wakode S.; Synthesis and pharmacological evaluation of pyrazole derivatives containing sulfonamide moiety. Monatsh Chem 2016,147(11),2017-2029","journal-title":"Monatsh Chem"},{"key":"ref=206","doi-asserted-by":"publisher","first-page":"104390","DOI":"10.1016\/j.bioorg.2020.104390","volume":"105","author":"Zhang B.","year":"2020","unstructured":"Zhang B.; Hu X-T.; Gu J.; Yang Y-S.; Duan Y-T.; Zhu H-L.; Discovery of novel sulfonamide-containing aminophosphonate derivatives as selective COX-2 inhibitors and anti-tumor candidates. Bioorg Chem 2020,105,104390","journal-title":"Bioorg Chem"},{"key":"ref=207","doi-asserted-by":"publisher","first-page":"22917","DOI":"10.1039\/C6RA02168A","volume":"6","author":"Lu X-Y.","year":"2016","unstructured":"Lu X-Y.; Wang Z-C.; Wei T.; Yan X-Q.; Wang P-F.; Zhu H-L.; Design, synthesis and evaluation of benzenesulfonamide-substituted 1, 5-diarylpyrazoles containing phenylacetohydrazide derivatives as COX-1\/COX-2 agents against solid tumors. RSC Advances 2016,6(27),22917-22935","journal-title":"RSC Advances"},{"key":"ref=208","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1134\/S1070363219110240","volume":"89","author":"Moustafa A.","year":"2019","unstructured":"Moustafa A.; El-Sayed H.; El Rayes S.; Morsy H.; Abd-allah S.; Ismail H.; Abd El-Aal M.; Pyrazoles and isoxazoles based sulfanilamide and phenazone as antimicrobial agents: Synthesis and biological activity. Russ J Gen Chem 2019,89(11),2314-2320","journal-title":"Russ J Gen Chem"},{"key":"ref=209","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.molstruc.2018.08.087","volume":"1176","author":"Fahim A.M.","year":"2019","unstructured":"Fahim A.M.; Shalaby M.A.; Synthesis, biological evaluation, molecular docking and DFT calculations of novel benzenesulfonamide derivatives. J Mol Struct 2019,1176,408-421","journal-title":"J Mol Struct"},{"key":"ref=210","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.3390\/ijms21072621","volume":"21","author":"Hargunani P.","year":"2020","unstructured":"Hargunani P.; Tadge N.; Ceruso M.; Leitans J.; Kazaks A.; Tars K.; Gratteri P.; Supuran C.T.; Nocentini A.; Toraskar M.P.; Aryl-4, 5-dihydro-1H-pyrazole-1-carboxa-] mide derivatives bearing a sulfonamide moiety show single-digit nanomolar-to-subnanomolar inhibition constants against the tumor-associated human carbonic anhydrases IX and XII. Int J Mol Sci 2020,21(7),2621","journal-title":"Int J Mol Sci"},{"key":"ref=211","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.bioorg.2018.01.021","volume":"77","author":"Gul H.I.","year":"2018","unstructured":"Gul H.I.; Yamali C.; Sakagami H.; Angeli A.; Leitans J.; Kazaks A.; Tars K.; Ozgun D.O.; Supuran C.T.; New anticancer drug candidates sulfonamides as selective hCA IX or hCA XII inhibitors. Bioorg Chem 2018,77,411-419","journal-title":"Bioorg Chem"},{"key":"ref=212","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1080\/14756366.2016.1243536","volume":"32","author":"Gul H.I.","year":"2017","unstructured":"Gul H.I.; Mete E.; Eren S.E.; Sakagami H.; Yamali C.; Supuran C.T.; Designing, synthesis and bioactivities of 4-[3-(4-hydroxyphenyl)-5-aryl-4, 5-dihydro-pyrazol-1-yl] benzenesulfonamides. J Enzyme Inhib Med Chem 2017,32(1),169-175","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=213","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.bioorg.2019.03.052","volume":"87","author":"Alaa A-M.","year":"2019","unstructured":"Alaa A-M.; El-Azab A.S.; Bua S.; Nocentini A.; El-Enin M.A.A.; Alanazi M.M.; AlSaif N.A.; Hefnawy M.M.; Supuran C.T.; Design, synthesis, and carbonic anhydrase inhibition activity of benzenesulfonamide-linked novel pyrazoline derivatives. Bioorg Chem 2019,87,425-431","journal-title":"Bioorg Chem"},{"key":"ref=214","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.bioorg.2018.12.028","volume":"84","author":"Ozgun D.O.","year":"2019","unstructured":"Ozgun D.O.; Gul H.I.; Yamali C.; Sakagami H.; Gulcin I.; Sukuroglu M.; Supuran C.T.; Synthesis and bioactivities of pyrazoline benzensulfonamides as carbonic anhydrase and acetylcholinesterase inhibitors with low cytotoxicity. Bioorg Chem 2019,84,511-517","journal-title":"Bioorg Chem"},{"key":"ref=215","doi-asserted-by":"publisher","first-page":"103627","DOI":"10.1016\/j.bioorg.2020.103627","volume":"96","author":"Yamali C.","year":"2020","unstructured":"Yamali C.; Gul H.I.; Kazaz C.; Levent S.; Gulcin I.; Synthesis, structure elucidation, and in vitro pharmacological evaluation of novel polyfluoro substituted pyrazoline type sulfonamides as multi-target agents for inhibition of acetylcholinesterase and carbonic anhydrase I and II enzymes. Bioorg Chem 2020,96,103627","journal-title":"Bioorg Chem"},{"key":"ref=216","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1021\/acs.jmedchem.6b01504","volume":"60","author":"Iyer M.R.","year":"2017","unstructured":"Iyer M.R.; Cinar R.; Katz A.; Gao M.; Erdelyi K.; Jourdan T.; Coffey N.J.; Pacher P.; Kunos G.; Design, synthesis, and biological evaluation of novel, non-brain-penetrant, hybrid cannabinoid CB1R inverse agonist\/inducible nitric oxide synthase (iNOS) inhibitors for the treatment of liver fibrosis. J Med Chem 2017,60(3),1126-1141","journal-title":"J Med Chem"},{"key":"ref=217","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.3390\/molecules24091685","volume":"24","author":"Yan X-Q.","year":"2019","unstructured":"Yan X-Q.; Wang Z-C.; Zhang B.; Qi P-F.; Li G-G.; Zhu H-L.; Dihydropyrazole derivatives containing benzo oxygen heterocycle and sulfonamide moieties selectively and potently inhibit COX-2: Design, synthesis, and anti-colon cancer activity evaluation. Molecules 2019,24(9),1685","journal-title":"Molecules"},{"key":"ref=218","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1080\/14756366.2016.1254207","volume":"32","author":"Gul H.I.","year":"2017","unstructured":"Gul H.I.; Yamali C.; Yesilyurt F.; Sakagami H.; Kucukoglu K.; Gulcin I.; Gul M.; Supuran C.T.; Microwave-assisted synthesis and bioevaluation of new sulfonamides. J Enzyme Inhib Med Chem 2017,32(1),369-374","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=219","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1007\/s00044-017-1838-5","volume":"26","author":"Sadashiva R.","year":"2017","unstructured":"Sadashiva R.; Naral D.; Kudva J.; Shivalingegowda N.; Lokanath N.K.; Pampa K.J.; Synthesis, spectral, biological activity, and crystal structure evaluation of novel pyrazoline derivatives having sulfonamide moiety. Med Chem Res 2017,26(6),1213-1227","journal-title":"Med Chem Res"},{"key":"ref=220","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ejmech.2015.07.036","volume":"102","author":"Lobo M.M.","year":"2015","unstructured":"Lobo M.M.; Oliveira S.M.; Brusco I.; Machado P.; Timmers L.F.; de Souza O.N.; Martins M.A.; Bonacorso H.G.; Dos Santos J.M.; Canova B.; da Silva T.V.F.; Zanatta N.; Regioselectively controlled synthesis of 3 (5)-(trifluoromethyl) pyrazolylbenzenesulfonamides and their effects on a pathological pain model in mice. Eur J Med Chem 2015,102,143-152","journal-title":"Eur J Med Chem"},{"key":"ref=221","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.ejmech.2019.03.052","volume":"171","author":"Hassan G.S.","year":"2019","unstructured":"Hassan G.S.; Rahman D.E.A.; Abdelmajeed E.A.; Refaey R.H.; Salem M.A.; Nissan Y.M.; New pyrazole derivatives: Synthesis, anti-inflammatory activity, cycloxygenase inhibition assay and evaluation of mPGES. Eur J Med Chem 2019,171,332-342","journal-title":"Eur J Med Chem"},{"key":"ref=222","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1002\/jhet.3147","volume":"55","author":"Zeid I.F.","year":"2018","unstructured":"Zeid I.F.; Kassem E.M.; Mohamed N.A.; Salman A.A.; Shalaby A.S.G.; Enhancement of different biomedical activities of newly synthesized quinazoline derivatives. J Heterocycl Chem 2018,55(6),1280-1290","journal-title":"J Heterocycl Chem"},{"key":"ref=223","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1248\/bpb.26.1711","volume":"26","author":"Alagarsamy V.","year":"2003","unstructured":"Alagarsamy V.; Murugananthan G.; Venkateshperumal R.; Synthesis, analgesic, anti-inflammatory and antibacterial activities of some novel 2-methyl-3-substituted quinazolin-4-(3H)-ones. Biol Pharm Bull 2003,26(12),1711-1714","journal-title":"Biol Pharm Bull"},{"key":"ref=224","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/j.bmcl.2015.01.010","volume":"25","author":"Rakesh K.","year":"2015","unstructured":"Rakesh K.; Manukumar H.; Gowda D.C.; Schiff\u2019s bases of quinazolinone derivatives: Synthesis and SAR studies of a novel series of potential anti-inflammatory and antioxidants. Bioorg Med Chem Lett 2015,25(5),1072-1077","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=225","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1111\/cbdd.12454","volume":"85","author":"Hu J.","year":"2015","unstructured":"Hu J.; Zhang Y.; Dong L.; Wang Z.; Chen L.; Liang D.; Shi D.; Shan X.; Liang G.; Design, synthesis, and biological evaluation of novel quinazoline derivatives as anti\u2010inflammatory agents against lipopolysaccharide\u2010induced acute lung injury in rats. Chem Biol Drug Des 2015,85(6),672-684","journal-title":"Chem Biol Drug Des"},{"key":"ref=226","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1080\/00397911.2018.1490433","volume":"48","author":"Hekal M.H.","year":"2018","unstructured":"Hekal M.H.; Abu El-Azm F.S.; New potential antitumor quinazolinones derived from dynamic 2-undecyl benzoxazinone: Synthesis and cytotoxic evaluation. Synth Commun 2018,48(18),2391-2402","journal-title":"Synth Commun"},{"key":"ref=227","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3390\/molecules21020189","volume":"21","author":"Ghorab M.M.","year":"2016","unstructured":"Ghorab M.M.; Alsaid M.S.; Al-Dosari M.S.; El-Gazzar M.G.; Parvez M.K.; Design, synthesis and anticancer evaluation of novel quinazoline-sulfonamide hybrids. Molecules 2016,21(2),189","journal-title":"Molecules"},{"key":"ref=228","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.bioorg.2019.03.007","volume":"87","author":"El-Azab A.S.","year":"2019","unstructured":"El-Azab A.S.; Alaa A-M.; Bua S.; Nocentini A.; El-Gendy M.A.; Mohamed M.A.; Shawer T.Z.; AlSaif N.A.; Supuran C.T.; Synthesis of benzensulfonamides linked to quinazoline scaffolds as novel carbonic anhydrase inhibitors. Bioorg Chem 2019,87,78-90","journal-title":"Bioorg Chem"},{"key":"ref=229","doi-asserted-by":"publisher","first-page":"8638","DOI":"10.1039\/C5NJ01408E","volume":"39","author":"Patel T.S.","year":"2015","unstructured":"Patel T.S.; Vanparia S.F.; Gandhi S.A.; Patel U.H.; Dixit R.B.; Chudasama C.J.; Dixit B.C.; Novel stereoselective 2, 3-disubstituted quinazoline-4 (3 H)-one derivatives derived from glycine as a potent antimalarial lead. New J Chem 2015,39(11),8638-8649","journal-title":"New J Chem"},{"key":"ref=230","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.ejmech.2017.02.012","volume":"129","author":"Patel T.S.","year":"2017","unstructured":"Patel T.S.; Vanparia S.F.; Patel U.H.; Dixit R.B.; Chudasama C.J.; Patel B.D.; Dixit B.C.; Novel 2, 3-disubstituted quinazoline-4 (3H)-one molecules derived from amino acid linked sulphonamide as a potent malarial antifolates for DHFR inhibition. Eur J Med Chem 2017,129,251-265","journal-title":"Eur J Med Chem"},{"key":"ref=231","doi-asserted-by":"publisher","first-page":"3161","DOI":"10.2147\/IJN.S241433","volume":"15","author":"Ghorab M.M.","year":"2020","unstructured":"Ghorab M.M.; Alqahtani A.S.; Soliman A.M.; Askar A.A.; Novel N.; -(Substituted) thioacetamide quinazolinone benzenesulfonamides as antimicrobial agents. Int J Nanomedicine 2020,15,3161-3180","journal-title":"Int J Nanomedicine"},{"key":"ref=232","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.molstruc.2019.04.050","volume":"1190","author":"Kumar A.S.","year":"2019","unstructured":"Kumar A.S.; Kudva J.; Lahtinen M.; Peuronen A.; Sadashiva R.; Naral D.; Synthesis, characterization, crystal structures and biological screening of 4-amino quinazoline sulfonamide derivatives. J Mol Struct 2019,1190,29-36","journal-title":"J Mol Struct"},{"key":"ref=233","doi-asserted-by":"publisher","first-page":"6635","DOI":"10.1016\/j.bmc.2017.10.041","volume":"25","author":"Patel T.S.","year":"2017","unstructured":"Patel T.S.; Bhatt J.D.; Vanparia S.F.; Patel U.H.; Dixit R.B.; Chudasama C.J.; Patel B.D.; Dixit B.C.; Ionic liquid mediated stereoselective synthesis of alanine linked hybrid quinazoline-4 (3H)-one derivatives perturbing the malarial reductase activity in folate pathway. Bioorg Med Chem 2017,25(24),6635-6646","journal-title":"Bioorg Med Chem"},{"key":"ref=234","doi-asserted-by":"publisher","first-page":"104345","DOI":"10.1016\/j.bioorg.2020.104345","volume":"104","author":"El-Azab A.S.","year":"2020","unstructured":"El-Azab A.S.; Alaa A-M.; AlSaif N.A.; Alkahtani H.M.; Alanazi M.M.; Obaidullah A.J.; Eskandrani R.O.; Alharbi A.; Antitumor activity, multitarget mechanisms, and molecular docking studies of quinazoline derivatives based on a benzenesulfonamide scaffold: Cell cycle analysis. Bioorg Chem 2020,104,104345","journal-title":"Bioorg Chem"},{"key":"ref=235","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.ejmech.2016.01.001","volume":"109","author":"Alafeefy A.M.","year":"2016","unstructured":"Alafeefy A.M.; Ahmad R.; Abdulla M.; Eldehna W.M.; Al-Tamimi A-M.S.; Abdel-Aziz H.A.; Al-Obaid O.; Carta F.; Al-Kahtani A.A.; Supuran C.T.; Development of certain new 2-substituted-quinazolin-4-yl-aminobenzenesul-] fonamide as potential antitumor agents. Eur J Med Chem 2016,109,247-253","journal-title":"Eur J Med Chem"},{"key":"ref=236","doi-asserted-by":"publisher","first-page":"3574","DOI":"10.1016\/j.bmc.2019.06.038","volume":"27","author":"Patel T.S.","year":"2019","unstructured":"Patel T.S.; Bhatt J.D.; Dixit R.B.; Chudasama C.J.; Patel B.D.; Dixit B.C.; Green synthesis, biological evaluation, molecular docking studies and 3D-QSAR analysis of novel phenylalanine linked quinazoline-4 (3H)-one-sulphonamide hybrid entities distorting the malarial reductase activity in folate pathway. Bioorg Med Chem 2019,27(16),3574-3586","journal-title":"Bioorg Med Chem"},{"key":"ref=237","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1016\/j.bmc.2017.03.054","volume":"25","author":"Bozdag M.","year":"2017","unstructured":"Bozdag M.; Alafeefy A.M.; Altamimi A.M.; Carta F.; Supuran C.T.; Vullo D.; Synthesis of new 3-(2-mercapto-4-oxo-4H-quinazolin-3-yl)-benzenesulfonamides with strong inhibition properties against the tumor associated carbonic anhydrases IX and XII. Bioorg Med Chem 2017,25(10),2782-2788","journal-title":"Bioorg Med Chem"},{"key":"ref=238","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1080\/14756366.2020.1722121","volume":"35","author":"El-Azab A.S.","year":"2020","unstructured":"El-Azab A.S.; Abdel-Aziz A.A-M.; Ahmed H.E.; Bua S.; Nocentini A.; AlSaif N.A.; Obaidullah A.J.; Hefnawy M.M.; Supuran C.T.; Exploring structure-activity relationship of S-substituted 2-mercaptoquinazolin-4 (3H)-one including 4-ethylbenzenesulfonamides as human carbonic anhydrase inhibitors. J Enzyme Inhib Med Chem 2020,35(1),598-609","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=239","doi-asserted-by":"publisher","first-page":"13586","DOI":"10.1002\/slct.201802402","volume":"3","author":"Kumar A.S.","year":"2018","unstructured":"Kumar A.S.; Kudva J.; Bharath B.; Rai V.M.; Kumar S.M.; Kumar V.; Sajankila S.P.; Synthesis, characterization, molecular docking studies and biological evaluation of some conjugated quinazoline\u2010sulfonamide scaffold. ChemistrySelect 2018,3(48),13586-13595","journal-title":"ChemistrySelect"},{"key":"ref=240","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1080\/14756366.2020.1742117","volume":"35","author":"El-Azab A.S.","year":"2020","unstructured":"El-Azab A.S.; Abdel-Aziz A.A.M.; Bua S.; Nocentini A.; AlSaif N.A.; Alanazi M.M.; El-Gendy M.A.; Ahmed H.E.A.; Supuran C.T.; S-substituted 2-mercaptoquinazolin-4(3H)-one and 4-ethylbenzensulfonamides act as potent and selective human carbonic anhydrase IX and XII inhibitors. J Enzyme Inhib Med Chem 2020,35(1),733-743","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=241","doi-asserted-by":"publisher","first-page":"7751","DOI":"10.1016\/j.bmc.2015.11.023","volume":"23","author":"Bozdag M.","year":"2015","unstructured":"Bozdag M.; Alafeefy A.M.; Vullo D.; Carta F.; Dedeoglu N.; Al-Tamimi A-M.S.; Al-Jaber N.A.; Scozzafava A.; Supuran C.T.; Benzenesulfonamides incorporating bulky aromatic\/heterocyclic tails with potent carbonic anhydrase inhibitory activity. Bioorg Med Chem 2015,23(24),7751-7764","journal-title":"Bioorg Med Chem"},{"key":"ref=242","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1016\/j.bmc.2016.02.011","volume":"24","author":"Alafeefy A.M.","year":"2016","unstructured":"Alafeefy A.M.; Carta F.; Ceruso M.; Al-Tamimi A-M.S.; Al-Kahtani A.A.; Supuran C.T.; Development of 3-(4-aminosulphonyl)-phenyl-2-mercapto-3H-quinazolin-4-ones as inhibitors of carbonic anhydrase isoforms involved in tumorigenesis and glaucoma. Bioorg Med Chem 2016,24(6),1402-1407","journal-title":"Bioorg Med Chem"},{"key":"ref=243","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1039\/C4MD00392F","volume":"6","author":"Farag D.B.","year":"2015","unstructured":"Farag D.B.; Farag N.A.; Esmat A.; Abuelezz S.A.; Abdel-Salam Ibrahim E.; Abou El Ella D.A.; Synthesis, 3D pharmacophore, QSAR and docking studies of novel quinazoline derivatives with nitric oxide release moiety as preferential COX-2 inhibitors. MedChemComm 2015,6(2),283-299","journal-title":"MedChemComm"},{"key":"ref=244","doi-asserted-by":"publisher","first-page":"4100","DOI":"10.1016\/j.bmc.2016.06.052","volume":"24","author":"Bozdag M.","year":"2016","unstructured":"Bozdag M.; Alafeefy A.M.; Carta F.; Ceruso M.; Al-Tamimi A-M.S.; Al-Kahtani A.A.; Alasmary F.A.S.; Supuran C.T.; Synthesis 4-[2-(2-mercapto-4-oxo-4H-quinazolin-3-yl)-ethyl]-benzenesulfonamides with subnanomolar carbonic anhydrase II and XII inhibitory properties. Bioorg Med Chem 2016,24(18),4100-4107","journal-title":"Bioorg Med Chem"},{"key":"ref=245","doi-asserted-by":"publisher","first-page":"592","DOI":"10.3109\/14756366.2014.957202","volume":"30","author":"Alafeefy A.M.","year":"2015","unstructured":"Alafeefy A.M.; Ceruso M.; Al-Tamimi A-M.S.; Prete S.D.; Supuran C.T.; Capasso C.; Inhibition studies of quinazoline-sulfonamide derivatives against the &#x3B3;-CA (PgiCA) from the pathogenic bacterium, Porphyromonas gingivalis. J Enzyme Inhib Med Chem 2015,30(4),592-596","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=246","doi-asserted-by":"publisher","first-page":"581","DOI":"10.3109\/14756366.2014.956309","volume":"30","author":"Alafeefy A.M.","year":"2015","unstructured":"Alafeefy A.M.; Ceruso M.; Al-Jaber N.A.; Parkkila S.; Vermelho A.B.; Supuran C.T.; A new class of quinazoline-sulfonamides acting as efficient inhibitors against the &#x3B1;-carbonic anhydrase from Trypanosoma cruzi. J Enzyme Inhib Med Chem 2015,30(4),581-585","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=247","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1016\/j.bmcl.2017.03.042","volume":"27","author":"Poudapally S.","year":"2017","unstructured":"Poudapally S.; Battu S.; Velatooru L.R.; Bethu M.S.; Janapala V.R.; Sharma S.; Sen S.; Pottabathini N.; Iska V.B.R.; Katangoor V.; Synthesis and biological evaluation of novel quinazoline-sulfonamides as anti-cancer agents. Bioorg Med Chem Lett 2017,27(9),1923-1928","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=248","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1080\/15257770.2019.1674331","volume":"39","author":"Tolan H.E.M.","year":"2020","unstructured":"Tolan H.E.M.; El-Sayed W.A.; Tawfek N.; Abdel-Megeid F.M.E.; Kutkat O.M.; Synthesis and anti-H5N1 virus activity of triazole- and oxadiazole-pyrimidine hybrids and their nucleoside analogs. Nucleosides Nucleotides Nucleic Acids 2020,39(5),649-670","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"ref=249","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s00044-020-02656-8","volume":"30","author":"Abdellatif K.R.A.","year":"2021","unstructured":"Abdellatif K.R.A.; Bakr R.B.; Pyrimidine and fused pyrimidine derivatives as promising protein kinase inhibitors for cancer treatment. Med Chem Res 2021,30(1),31-49","journal-title":"Med Chem Res"},{"key":"ref=250","doi-asserted-by":"publisher","first-page":"5618","DOI":"10.3390\/molecules16075618","volume":"16","author":"Sun L.","year":"2011","unstructured":"Sun L.; Wu J.; Zhang L.; Luo M.; Sun D.; Synthesis and antifungal activities of some novel pyrimidine derivatives. Molecules 2011,16(7),5618-5628","journal-title":"Molecules"},{"key":"ref=251","doi-asserted-by":"publisher","first-page":"337","DOI":"10.4103\/0250-474X.34540","volume":"69","author":"Amir M.","year":"2007","unstructured":"Amir M.; Javed S.; Kumar H.; Pyrimidine as antiinflammatory agent: A review. Indian J Pharm Sci 2007,69(3),337","journal-title":"Indian J Pharm Sci"},{"key":"ref=252","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1007\/s00044-019-02289-6","volume":"28","author":"Farghaly A.M.","year":"2019","unstructured":"Farghaly A.M.; AboulWafa, O.M.; Elshaier, Y.A.M.; Badawi, W.A.; Haridy, H.H.; Mubarak, H.A.E. AboulWafa, O.M.; Elshaier, Y.A.; Badawi, W.A.; Haridy, H.H.; Mubarak, H.A., Design, synthesis, and antihypertensive activity of new pyrimidine derivatives endowing new pharmacophores. Med Chem Res 2019,28(3),360-379","journal-title":"Med Chem Res"},{"key":"ref=253","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1080\/15257770.2016.1257808","volume":"36","author":"Elgemeie G.H.","year":"2017","unstructured":"Elgemeie G.H.; Salah A.M.; Abbas N.S.; Hussein H.A.; Mohamed R.A.; Pyrimidine non-nucleoside analogs: A direct synthesis of a novel class of N-substituted amino and N-sulfonamide derivatives of pyrimidines. Nucleosides Nucleotides Nucleic Acids 2017,36(3),213-223","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"ref=254","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1007\/s00044-011-9653-x","volume":"21","author":"Ghorab M.M.","year":"2012","unstructured":"Ghorab M.M.; Ragab F.A.; Heiba H.I.; Youssef H.A.; El-Gazzar M.G.; Synthesis of novel pyrazole and pyrimidine derivatives bearing sulfonamide moiety as antitumor and radiosensitizing agents. Med Chem Res 2012,21(7),1376-1383","journal-title":"Med Chem Res"},{"key":"ref=255","doi-asserted-by":"publisher","first-page":"3445","DOI":"10.1016\/j.bmcl.2012.03.092","volume":"22","author":"Keche A.P.","year":"2012","unstructured":"Keche A.P.; Hatnapure G.D.; Tale R.H.; Rodge A.H.; Birajdar S.S.; Kamble V.M.; A novel pyrimidine derivatives with aryl urea, thiourea and sulfonamide moieties: Synthesis, anti-inflammatory and antimicrobial evaluation. Bioorg Med Chem Lett 2012,22(10),3445-3448","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=256","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13065-017-0258-4","volume":"11","author":"Ghorab M.M.","year":"2017","unstructured":"Ghorab M.M.; Alsaid M.S.; El-Gaby M.S.; Elaasser M.M.; Nissan Y.M.; Antimicrobial and anticancer activity of some novel fluorinated thiourea derivatives carrying sulfonamide moieties: Synthesis, biological evaluation and molecular docking. Chem Cent J 2017,11(1),1-14","journal-title":"Chem Cent J"},{"key":"ref=257","doi-asserted-by":"publisher","first-page":"115329","DOI":"10.1016\/j.bmc.2020.115329","volume":"28","author":"Abdel-Mohsen H.T.","year":"2020","unstructured":"Abdel-Mohsen H.T.; El Kerdawy A.M.; Omar M.A.; Berrino E.; Abdelsamie A.S.; El Diwani H.I.; Supuran C.T.; New thiopyrimidine-benzenesulfonamide conjugates as selective carbonic anhydrase II inhibitors: Synthesis, in vitro biological evaluation, and molecular docking studies. Bioorg Med Chem 2020,28(5),115329","journal-title":"Bioorg Med Chem"},{"key":"ref=258","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.2174\/1871520617666170327153735","volume":"17","author":"Ghorab M.","year":"2017","unstructured":"Ghorab M.; El-Gaby M.S.A.; Alsaid M.S.; Elshaier Y.A.M.M.; Soliman A.M.; El-Senduny F.F.; Badria F.A.; Sherif A.Y.A.; Novel thiourea derivatives bearing sulfonamide moiety as anticancer agents through COX-2 inhibition. Anticancer Agents Med Chem 2017,17(10),1411-1425","journal-title":"Anticancer Agents Med Chem"},{"key":"ref=259","doi-asserted-by":"publisher","first-page":"3989","DOI":"10.1016\/j.bmc.2017.05.044","volume":"25","author":"Qu M.","year":"2017","unstructured":"Qu M.; Liu Z.; Zhao D.; Wang C.; Zhang J.; Tang Z.; Liu K.; Shu X.; Yuan H.; Ma X.; Design, synthesis and biological evaluation of sulfonamide-substituted diphenylpyrimidine derivatives (Sul-DPPYs) as potent focal adhesion kinase (FAK) inhibitors with antitumor activity. Bioorg Med Chem 2017,25(15),3989-3996","journal-title":"Bioorg Med Chem"},{"key":"ref=260","doi-asserted-by":"publisher","first-page":"112112","DOI":"10.1016\/j.ejmech.2020.112112","volume":"190","author":"Petreni A.","year":"2020","unstructured":"Petreni A.; Bonardi A.; Lomelino C.; Osman S.M.; ALOthman, Z.A.; Eldehna, W.M.; El-Haggar, R.; McKenna, R.; Nocentini, A.; Supuran, C.T. Inclusion of a 5-fluorouracil moiety in nitrogenous bases derivatives as human carbonic anhydrase IX and XII inhibitors produced a targeted action against MDA-MB-231 and T47D breast cancer cells. Eur J Med Chem 2020,190,112112","journal-title":"Eur J Med Chem"},{"key":"ref=261","first-page":"65","volume":"9","author":"Awad S.M.","year":"2017","unstructured":"Awad S.M.; El-Shehry M.F.; Gouhar R.S.; El-Hallouty S.M.; Synthesis, characterization and antitumor activity of some novel pyrimidine sulphonamide derivatives. J Chem Pharm Res 2017,9(6),65-73","journal-title":"J Chem Pharm Res"},{"key":"ref=262","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1080\/14756366.2016.1198900","volume":"31","author":"Gokcen T.","year":"2016","unstructured":"Gokcen T.; Gulcin I.; Ozturk T.; Goren A.C.; A class of sulfonamides as carbonic anhydrase I and II inhibitors. J Enzyme Inhib Med Chem 2016,31(sup2),180-188","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=263","first-page":"5534","volume":"9","author":"Jyothi B.","year":"2018","unstructured":"Jyothi B.; Madhavi N.; Synthesis and biological screening of pyrimidine linked benzene sulfonamide derivatives. Int J Pharm Sci Res 2018,9,5534-5543","journal-title":"Int J Pharm Sci Res"},{"key":"ref=264","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ejmech.2017.04.037","volume":"135","author":"Liu H.","year":"2017","unstructured":"Liu H.; Qu M.; Xu L.; Han X.; Wang C.; Shu X.; Yao J.; Liu K.; Peng J.; Li Y.; Ma X.; Design and synthesis of sulfonamide-substituted diphenylpyrimidines (SFA-DPPYs) as potent Bruton\u2019s tyrosine kinase (BTK) inhibitors with improved activity toward B-cell lymphoblastic leukemia. Eur J Med Chem 2017,135,60-69","journal-title":"Eur J Med Chem"},{"key":"ref=265","doi-asserted-by":"publisher","first-page":"793","DOI":"10.3390\/molecules22060793","volume":"22","author":"K&#xF6;ksal Z.","year":"2017","unstructured":"K&#xF6;ksal Z.; Kalin R.; Camadan Y.; Usanmaz H.; Almaz Z.; G&#xFC;l&#xE7;in I.; Gokcen T.; G&#xF6;ren A.C.; Ozdemir H.; Secondary sulfonamides as effective lactoperoxidase inhibitors. Molecules 2017,22(6),793","journal-title":"Molecules"},{"key":"ref=266","doi-asserted-by":"publisher","first-page":"103539","DOI":"10.1016\/j.bioorg.2019.103539","volume":"95","author":"Mettu A.","year":"2020","unstructured":"Mettu A.; Talla V.; Thumma S.; Prameela S.N.J.; Mechanistic investigations on substituted benzene sulphonamides as apoptosis inducing anticancer agents. Bioorg Chem 2020,95,103539","journal-title":"Bioorg Chem"},{"key":"ref=267","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1111\/cbdd.12678","volume":"87","author":"Xiang J.","year":"2016","unstructured":"Xiang J.; Leung C.; Zhang Z.; Hu C.; Geng C.; Liu L.; Yi L.; Li Z.; Berenson J.; Bai X.; Synthesis and evaluation of 2-alkylthio-4-(N-substituted sulfonamide)pyrimidine hydroxamic acids as anti-myeloma agents. Chem Biol Drug Des 2016,87(3),472-477","journal-title":"Chem Biol Drug Des"},{"key":"ref=268","first-page":"e2000230","volume":"2002","author":"Tugrak M.","year":"2020","unstructured":"Tugrak M.; Gul H.I.; Demir Y.; Gulcin I.; Synthesis of benzamide derivatives with thiourea\u2010substituted benzenesulfonamides as carbonic anhydrase inhibitors. Arch Pharm 2020,2002,e2000230","journal-title":"Arch Pharm"},{"key":"ref=269","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.3109\/14756366.2015.1079183","volume":"31","author":"Aday B.","year":"2016","unstructured":"Aday B.; Sola P.; &#xC7;olak F.; Kaya M.; Synthesis of novel sulfonamide analogs containing sulfamerazine\/sulfagua-] nidine and their biological activities. J Enzyme Inhib Med Chem 2016,31(6),1005-1010","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=270","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.arabjc.2017.05.022","volume":"13","author":"Ghorab M.M.","year":"2020","unstructured":"Ghorab M.M.; Soliman A.M.; Alsaid M.S.; Askar A.A.; Synthesis, antimicrobial activity and docking study of some novel 4-(4, 4-dimethyl-2, 6-dioxocyclohexylidene) methylamino derivatives carrying biologically active sulfonamide moiety. Arab J Chem 2020,13(1),545-556","journal-title":"Arab J Chem"},{"key":"ref=271","doi-asserted-by":"publisher","first-page":"4397","DOI":"10.1016\/j.bmc.2017.06.022","volume":"25","author":"Huang B.","year":"2017","unstructured":"Huang B.; Wang X.; Liu X.; Chen Z.; Li W.; Sun S.; Liu H.; Daelemans D.; De Clercq E.; Pannecouque C.; Zhan P.; Liu X.; Discovery of novel DAPY-IAS hybrid derivatives as potential HIV-1 inhibitors using molecular hybridization based on crystallographic overlays. Bioorg Med Chem 2017,25(16),4397-4406","journal-title":"Bioorg Med Chem"},{"key":"ref=272","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1039\/C8NJ04385J","volume":"43","author":"Puratchikody A.","year":"2019","unstructured":"Puratchikody A.; Umamaheswari A.; Irfan N.; Sinha S.; Manju S.; Ramanan M.; Ramamoorthy G.; Doble M.; A novel class of tyrosine derivatives as dual 5-LOX and COX-2\/mPGES1 inhibitors with PGE 2 mediated anticancer properties. New J Chem 2019,43(2),834-846","journal-title":"New J Chem"},{"key":"ref=273","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1002\/jhet.2827","volume":"54","author":"Mishra R.","year":"2017","unstructured":"Mishra R.; Sharma P.K.; Verma P.K.; Tomer I.; Mathur G.; Dhakad P.K.; Biological potential of thiazole derivatives of synthetic origin. J Heterocycl Chem 2017,54(4),2103-2116","journal-title":"J Heterocycl Chem"},{"key":"ref=274","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.ejmech.2008.04.022","volume":"44","author":"Karthikeyan M.S.","year":"2009","unstructured":"Karthikeyan M.S.; Synthesis, analgesic, anti-inflammatory and antimicrobial studies of 2, 4-dichloro-5-fluorophenyl containing thiazolotriazoles. Eur J Med Chem 2009,44(2),827-833","journal-title":"Eur J Med Chem"},{"key":"ref=275","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.ejmech.2013.04.005","volume":"65","author":"Helal M.","year":"2013","unstructured":"Helal M.; Salem M.; El-Gaby M.; Aljahdali M.; Synthesis and biological evaluation of some novel thiazole compounds as potential anti-inflammatory agents. Eur J Med Chem 2013,65,517-526","journal-title":"Eur J Med Chem"},{"key":"ref=276","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.4155\/fmc-2018-0416","volume":"11","author":"Ayati A.","year":"2019","unstructured":"Ayati A.; Emami S.; Moghimi S.; Foroumadi A.; Thiazole in the targeted anticancer drug discovery. Future Med Chem 2019,11(16),1929-1952","journal-title":"Future Med Chem"},{"key":"ref=277","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1021\/acsmedchemlett.9b00644","volume":"11","author":"Meleddu R.","year":"2020","unstructured":"Meleddu R.; Distinto S.; Cottiglia F.; Angius R.; Caboni P.; Angeli A.; Melis C.; Deplano S.; Alcaro S.; Ortuso F.; Supuran C.T.; Maccioni E.; New dihydrothiazole benzensulfonamides: looking for selectivity toward carbonic anhydrase isoforms I, II, IX, and XII. ACS Med Chem Lett 2020,11(5),852-856","journal-title":"ACS Med Chem Lett"},{"key":"ref=278","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1134\/S1070428019060162","volume":"55","author":"Pour Z.R.","year":"2019","unstructured":"Pour Z.R.; Nazifi S.; Safavi A.A.; Nazifi Z.; Massah A.; Solvent-free synthesis, ADME prediction, and evaluation of antibacterial activity of novel sulfonamide derivatives. Russ J Org Chem 2019,55(6),852-859","journal-title":"Russ J Org Chem"},{"key":"ref=279","doi-asserted-by":"publisher","first-page":"2000102","DOI":"10.1002\/ardp.202000102","volume":"353","author":"I&#x15F;\u0131k M.","year":"2020","unstructured":"I&#x15F;\u0131k M.; Akocak S.; Lolak N.; Taslimi P.; T&#xFC;rke&#x15F; C.; G&#xFC;l&#xE7;in \u0130.; Durgun M.; Beydemir &#x15E;.; Synthesis, characterization, biological evaluation, and in silico studies of novel 1, 3\u2010diaryltriazene\u2010substituted sulfathiazole derivatives. Arch Pharm (Weinheim) 2020,353(9),2000102","journal-title":"Arch Pharm (Weinheim)"},{"key":"ref=280","doi-asserted-by":"publisher","first-page":"9618","DOI":"10.1021\/acs.jmedchem.9b01032","volume":"62","author":"Focken T.","year":"2019","unstructured":"Focken T.; Burford K.; Grimwood M.E.; Zenova A.; Andrez J-C.; Gong W.; Wilson M.; Taron M.; Decker S.; Lofstrand V.; Chowdhury S.; Shuart N.; Lin S.; Goodchild S.J.; Young C.; Soriano M.; Tari P.K.; Waldbrook M.; Nelkenbrecher K.; Kwan R.; Lindgren A.; de Boer G.; Lee S.; Sojo L.; DeVita R.J.; Cohen C.J.; Wesolowski S.S.; Johnson J.P.; Dehnhardt C.M.; Empfield J.R.; Identification of CNS-penetrant aryl sulfonamides as isoform-selective NaV1. 6 inhibitors with efficacy in mouse models of epilepsy. J Med Chem 2019,62(21),9618-9641","journal-title":"J Med Chem"},{"key":"ref=281","doi-asserted-by":"publisher","first-page":"8276","DOI":"10.1021\/acs.jmedchem.6b00547","volume":"59","author":"Millet A.","year":"2016","unstructured":"Millet A.; Plaisant M.; Ronco C.; Cerezo M.; Abbe P.; Jaune E.; Cavazza E.; Rocchi S.; Benhida R.; Discovery and optimization of N-(4-(3-aminophenyl) thiazol-2-yl) acetamide as a novel scaffold active against sensitive and resistant cancer cells. J Med Chem 2016,59(18),8276-8292","journal-title":"J Med Chem"},{"key":"ref=282","doi-asserted-by":"publisher","first-page":"3414","DOI":"10.1016\/j.bmc.2018.05.015","volume":"26","author":"Naaz F.","year":"2018","unstructured":"Naaz F.; Srivastava R.; Singh A.; Singh N.; Verma R.; Singh V.K.; Singh R.K.; Molecular modeling, synthesis, antibacterial and cytotoxicity evaluation of sulfonamide derivatives of benzimidazole, indazole, benzothiazole and thiazole. Bioorg Med Chem 2018,26(12),3414-3428","journal-title":"Bioorg Med Chem"},{"key":"ref=283","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3390\/ph13060118","volume":"13","author":"Roy S.","year":"2020","unstructured":"Roy S.; Mahapatra A.D.; Mohammad T.; Gupta P.; Alajmi M.F.; Hussain A.; Rehman M.; Datta B.; Hassan M.; Design and development of novel urea, sulfonyltriurea, and sulfonamide derivatives as potential inhibitors of sphingosine kinase 1. Pharmaceuticals (Basel) 2020,13(6),118","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref=284","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/cbdd.12675","volume":"87","author":"Saeed A.","year":"2016","unstructured":"Saeed A.; Mahmood S.; Rafiq M.; Ashraf Z.; Jabeen F.; Seo S-Y.; Iminothiazoline\u2010sulfonamide hybrids as Jack Bean Urease inhibitors; Synthesis, kinetic mechanism and computational molecular modeling. Chem Biol Drug Des 2016,87(3),434-443","journal-title":"Chem Biol Drug Des"},{"key":"ref=285","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1080\/10426507.2015.1100183","volume":"191","author":"Fadda A.A.","year":"2016","unstructured":"Fadda A.A.; El-badraw A.M.; Refat H.M.; Abdel-Latif E.; Synthesis of some new 2-substituted-4-sulfamoylpheny-] lazo-thiophene and\/or thiazole derivatives as antibacterial agents. Phosphorus Sulfur Silicon Relat Elem 2016,191(5),778-785","journal-title":"Phosphorus Sulfur Silicon Relat Elem"},{"key":"ref=286","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1021\/jm501504k","volume":"58","author":"Zhao L.","year":"2015","unstructured":"Zhao L.; Wang Y.; Cao D.; Chen T.; Wang Q.; Li Y.; Xu Y.; Zhang N.; Wang X.; Chen D.; Chen L.; Chen Y-L.; Xia G.; Shi Z.; Liu Y-C.; Lin Y.; Miao Z.; Shen J.; Xiong B.; Fragment-based drug discovery of 2-thiazolidinones as BRD4 inhibitors: 2. Structure-based optimization. J Med Chem 2015,58(3),1281-1297","journal-title":"J Med Chem"},{"key":"ref=287","doi-asserted-by":"publisher","first-page":"e1800231","DOI":"10.1002\/cbdv.201800231","volume":"15","author":"Riyadh S.M.","year":"2018","unstructured":"Riyadh S.M.; El\u2010Motairi S.A.; Ahmed H.E.; Khalil K.D.; Habib E.S.E.; Synthesis, biological evaluation, and molecular docking of novel thiazoles and [1, 3, 4] thiadiazoles incorporating sulfonamide group as DHFR Inhibitors. Chem Biodivers 2018,15(9),e1800231","journal-title":"Chem Biodivers"},{"key":"ref=288","doi-asserted-by":"publisher","first-page":"e22596","DOI":"10.1002\/jbt.22596","volume":"34","author":"Berber N.","year":"2020","unstructured":"Berber N.; Arslan M.; Vural F.; Ergun A.; Gen&#xE7;er N.; Arslan O.; Synthesis of new series of thiazol\u2010(2 (3H)\u2010ylideneamino) benzenesulfonamide derivatives as carbonic anhydrase inhibitors. J Biochem Mol Toxicol 2020,34(12),e22596","journal-title":"J Biochem Mol Toxicol"},{"key":"ref=289","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.bioorg.2017.08.017","volume":"75","author":"Va\u0161kevi&#x10D;ien\u0117 I.","year":"2017","unstructured":"Va\u0161kevi&#x10D;ien\u0117 I.; Paketuryt\u0117 V.; Zubrien\u0117 A.; Kantminien\u0117 K.; Mickevi&#x10D;ius V.; Matulis D.; N-Sulfa-] moylphenyl-and N-sulfamoylphenyl-N-thiazolyl-&#x3B2;-alanines and their derivatives as inhibitors of human carbonic anhydrases. Bioorg Chem 2017,75,16-29","journal-title":"Bioorg Chem"},{"key":"ref=290","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.1016\/j.bmc.2016.05.016","volume":"24","author":"Gawad N.M.A.","year":"2016","unstructured":"Gawad N.M.A.; Amin N.H.; Elsaadi M.T.; Mohamed F.M.; Angeli A.; De Luca V.; Capasso C.; Supuran C.T.; Synthesis of 4-(thiazol-2-ylamino)-benzenesulfonamides with carbonic anhydrase I, II and IX inhibitory activity and cytotoxic effects against breast cancer cell lines. Bioorg Med Chem 2016,24(13),3043-3051","journal-title":"Bioorg Med Chem"},{"key":"ref=291","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.bioorg.2019.04.002","volume":"87","author":"Abo-Ashour M.F.","year":"2019","unstructured":"Abo-Ashour M.F.; Eldehna W.M.; Nocentini A.; Ibrahim H.S.; Bua S.; Abdel-Aziz H.A.; Abou-Seri S.M.; Supuran C.T.; Novel synthesized SLC-0111 thiazole and thiadiazole analogues: Determination of their carbonic anhydrase inhibitory activity and molecular modeling studies. Bioorg Chem 2019,87,794-802","journal-title":"Bioorg Chem"},{"key":"ref=292","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.molstruc.2019.04.048","volume":"1194","author":"Abd El-Gilil S.M.","year":"2019","unstructured":"Abd El-Gilil S.M.; Design, synthesis, molecular docking and biological screening of N-ethyl-N-methylbenzenesul-] fonamide derivatives as effective antimicrobial and antiproliferative agents. J Mol Struct 2019,1194,144-156","journal-title":"J Mol Struct"},{"key":"ref=293","first-page":"79","volume":"72","author":"Ghorab M.M.","year":"2015","unstructured":"Ghorab M.M.; Alsaid M.S.; Cytotoxic activity of some novel sulfonamide derivatives. Acta Pol Pharm 2015,72(1),79-87","journal-title":"Acta Pol Pharm"},{"key":"ref=294","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13065-019-0532-8","volume":"13","author":"Grewal A.S.","year":"2019","unstructured":"Grewal A.S.; Kharb R.; Prasad D.N.; Dua J.S.; Lather V.; Design, synthesis and evaluation of novel 3, 5-disubstituted benzamide derivatives as allosteric glucokinase activators. BMC Chem 2019,13(1),1-14","journal-title":"BMC Chem"},{"key":"ref=295","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.bioorg.2018.01.031","volume":"77","author":"Mahmood S.","year":"2018","unstructured":"Mahmood S.; Saeed A.; Bua S.; Nocentini A.; Gratteri P.; Supuran C.T.; Synthesis, biological evaluation and computational studies of novel iminothiazolidinone benzenesulfonamides as potent carbonic anhydrase II and IX inhibitors. Bioorg Chem 2018,77,381-386","journal-title":"Bioorg Chem"},{"key":"ref=296","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1039\/C8NJ03671C","volume":"43","author":"Kumar A.S.","year":"2019","unstructured":"Kumar A.S.; Kudva J.; Bharath B.; Ananda K.; Sadashiva R.; Kumar S.M.; Revanasiddappa B.; Kumar V.; Rekha P.; Naral D.; Synthesis, structural, biological and in silico studies of new 5-arylidene-4-thiazolidinone derivatives as possible anticancer, antimicrobial and antitubercular agents. New J Chem 2019,43(3),1597-1610","journal-title":"New J Chem"},{"key":"ref=297","doi-asserted-by":"publisher","first-page":"128916","DOI":"10.1016\/j.molstruc.2020.128916","volume":"1222","author":"Khadse S.C.","year":"2020","unstructured":"Khadse S.C.; Amnerkar N.D.; Dighole K.S.; Dhote A.M.; Patil V.R.; Lokwani D.K.; Ugale V.G.; Charbe N.B.; Chatpalliwar V.A.; Hetero-substituted sulfonamido-benza-] mide hybrids as glucokinase activators: Design, synthesis, molecular docking and in-silico ADME evaluation. J Mol Struct 2020,1222,128916","journal-title":"J Mol Struct"},{"key":"ref=298","doi-asserted-by":"publisher","first-page":"3281","DOI":"10.1016\/j.bmcl.2015.05.076","volume":"25","author":"Meleddu R.","year":"2015","unstructured":"Meleddu R.; Maccioni E.; Distinto S.; Bianco G.; Melis C.; Alcaro S.; Cottiglia F.; Ceruso M.; Supuran C.T.; New 4-[(3-cyclohexyl-4-aryl-2, 3-dihydro-1, 3-thiazol-2-ylidene) amino] benzene-1-sulfonamides, synthesis and inhibitory activity toward carbonic anhydrase I, II, IX, XII. Bioorg Med Chem Lett 2015,25(16),3281-3284","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=299","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1021\/acsmedchemlett.8b00352","volume":"9","author":"Meleddu R.","year":"2018","unstructured":"Meleddu R.; Distinto S.; Cottiglia F.; Angius R.; Gaspari M.; Taverna D.; Melis C.; Angeli A.; Bianco G.; Deplano S.; Fois B.; Del Prete S.; Capasso C.; Alcaro S.; Ortuso F.; Yanez M.; Supuran C.T.; Maccioni E.; Tuning the dual inhibition of carbonic anhydrase and cyclooxygenase by dihydrothiazole benzensulfonamides. ACS Med Chem Lett 2018,9(10),1045-1050","journal-title":"ACS Med Chem Lett"},{"key":"ref=300","first-page":"158","volume":"10","author":"Shinde R.R.","year":"2020","unstructured":"Shinde R.R.; Dhawale S.A.; Farooqui M.; Design, synthesis and anti-microbial study of ethyl 2-(N-(substituted-phenyl) sulfamoyl) thiazole-4-carboxylate derivatives. Chem Biol Interact 2020,10(6),158-172","journal-title":"Chem Biol Interact"},{"key":"ref=301","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1021\/acs.jmedchem.5b01311","volume":"59","author":"Rutaganira F.U.","year":"2016","unstructured":"Rutaganira F.U.; Fowler M.L.; McPhail J.A.; Gelman M.A.; Nguyen K.; Xiong A.; Dornan G.L.; Tavshanjian B.; Glenn J.S.; Shokat K.M.; Burke J.E.; Design and structural characterization of potent and selective inhibitors of phosphatidylinositol 4 kinase III&#x3B2;. J Med Chem 2016,59(5),1830-1839","journal-title":"J Med Chem"},{"key":"ref=302","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.bioorg.2018.02.004","volume":"77","author":"&#x10C;apkauskait\u0117 E.","year":"2018","unstructured":"&#x10C;apkauskait\u0117 E.; Zubrien\u0117 A.; Paketuryt\u0117 V.; Timm D.D.; Tumkevi&#x10D;ius S.; Matulis D.; Thiazole-substituted benzenesulfonamides as inhibitors of 12 human carbonic anhydrases. Bioorg Chem 2018,77,534-541","journal-title":"Bioorg Chem"},{"key":"ref=303","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.ejmech.2017.04.069","volume":"135","author":"Mohamed K.O.","year":"2017","unstructured":"Mohamed K.O.; Nissan Y.M.; El-Malah A.A.; Ahmed W.A.; Ibrahim D.M.; Sakr T.M.; Motaleb M.A.; Design, synthesis and biological evaluation of some novel sulfonamide derivatives as apoptosis inducers. Eur J Med Chem 2017,135,424-433","journal-title":"Eur J Med Chem"},{"key":"ref=304","first-page":"1800170","volume":"352","author":"Tariq S.","year":"2019","unstructured":"Tariq S.; Kamboj P.; Amir M.; Therapeutic advancement of benzothiazole derivatives in the last decennial period. Arch Pharm 2019,352(1),1800170","journal-title":"Arch Pharm"},{"key":"ref=305","doi-asserted-by":"publisher","first-page":"5218","DOI":"10.2174\/0929867324666171009103327","volume":"25","author":"Gjorgjieva M.","year":"2018","unstructured":"Gjorgjieva M.; Toma\u0161i&#x10D; T.; Kikelj D.; Ma\u0161i&#x10D; L.P.; Benzothiazole-based compounds in antibacterial drug discovery. Curr Med Chem 2018,25(38),5218-5236","journal-title":"Curr Med Chem"},{"key":"ref=306","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1080\/14756366.2019.1698036","volume":"35","author":"Irfan A.","year":"2020","unstructured":"Irfan A.; Batool F.; Zahra Naqvi S.A.; Islam A.; Osman S.M.; Nocentini A.; Alissa S.A.; Supuran C.T.; Benzothiazole derivatives as anticancer agents. J Enzyme Inhib Med Chem 2020,35(1),265-279","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=307","doi-asserted-by":"publisher","first-page":"104259","DOI":"10.1016\/j.bioorg.2020.104259","volume":"104","author":"Mokhtar A.M.","year":"2020","unstructured":"Mokhtar A.M.; El-Messery S.M.; Ghaly M.A.; Hassan G.S.; Targeting EGFR tyrosine kinase: Synthesis, in vitro antitumor evaluation, and molecular modeling studies of benzothiazole-based derivatives. Bioorg Chem 2020,104,104259","journal-title":"Bioorg Chem"},{"key":"ref=308","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3390\/molecules21030164","volume":"21","author":"Liu D-C.","year":"2016","unstructured":"Liu D-C.; Zhang H-J.; Jin C-M.; Quan Z-S.; Synthesis and biological evaluation of novel benzothiazole derivatives as potential anticonvulsant agents. Molecules 2016,21(3),164","journal-title":"Molecules"},{"key":"ref=309","doi-asserted-by":"publisher","first-page":"7035","DOI":"10.1080\/07391102.2020.1804459","volume":"39","author":"Ujan R.","year":"2020","unstructured":"Ujan R.; Saeed A.; Ashraf S.; Channar P.A.; Abbas Q.; Rind M.A.; Hassan M.; Raza H.; Seo S-Y.; El-Seedi H.R.; Synthesis, computational studies and enzyme inhibitory kinetics of benzothiazole-linked thioureas as mushroom tyrosinase inhibitors. J Biomol Struct Dyn 2020,39(18),7035-7043","journal-title":"J Biomol Struct Dyn"},{"key":"ref=310","doi-asserted-by":"publisher","first-page":"6945","DOI":"10.1016\/j.bmc.2014.10.018","volume":"22","author":"Ceruso M.","year":"2014","unstructured":"Ceruso M.; Khloya P.; Supuran C.T.; Sharma P.K.; 4-Functionalized 1, 3-diarylpyrazoles bearing 6-aminosul-] fonylbenzothiazole moiety as potent inhibitors of carbonic anhydrase isoforms hCA I, II, IX and XII. Bioorg Med Chem 2014,22(24),6945-6952","journal-title":"Bioorg Med Chem"},{"key":"ref=311","first-page":"1","volume":"18","author":"Khokra S.L.","year":"2019","unstructured":"Khokra S.L.; Arora K.; Khan S.A.; Kaushik P.; Saini R.; Husain A.; synthesis, computational studies and anticonvulsant activity of novel benzothiazole coupled sulfonamide derivatives. Iran J Pharm Res 2019,18(1),1-15","journal-title":"Iran J Pharm Res"},{"key":"ref=312","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3390\/molecules22020153","volume":"22","author":"Obasi L.N.","year":"2017","unstructured":"Obasi L.N.; Oruma U.S.; Al-Swaidan I.A.; Ramasami P.; Ezeorah C.J.; Ochonogor A.E.; Synthesis, characterization and antibacterial studies of N-(Benzothiazol-2-yl)-4-chlorobenzenesulphonamide and Its neodymium (III) and thallium (III) complexes. Molecules 2017,22(2),153","journal-title":"Molecules"},{"key":"ref=313","first-page":"154","volume":"13","author":"Jagtap S.","year":"2020","unstructured":"Jagtap S.; Bahule B.; Ahmed K.; Gaikwad D.; Design, synthesis and anti-microbial study of 6-amino-N-substtituted-benzo [d] thiazole-2-sulfonamide derivatives. Int J Future Gener Commun Netw 2020,13,154-160","journal-title":"Int J Future Gener Commun Netw"},{"key":"ref=314","doi-asserted-by":"publisher","first-page":"103437","DOI":"10.1016\/j.bioorg.2019.103437","volume":"94","author":"Ismail M.M.","year":"2020","unstructured":"Ismail M.M.; Abdulwahab H.G.; Nossier E.S.; El Menofy N.G.; Abdelkhalek B.A.; Synthesis of novel 2-aminobenzothiazole derivatives as potential antimicrobial agents with dual DNA gyrase\/topoisomerase IV inhibition. Bioorg Chem 2020,94,103437","journal-title":"Bioorg Chem"},{"key":"ref=315","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/j.bmcl.2016.08.032","volume":"27","author":"Lad N.P.","year":"2017","unstructured":"Lad N.P.; Manohar Y.; Mascarenhas M.; Pandit Y.B.; Kulkarni M.R.; Sharma R.; Salkar K.; Suthar A.; Pandit S.S.; Methylsulfonyl benzothiazoles (MSBT) derivatives: Search for new potential antimicrobial and anticancer agents. Bioorg Med Chem Lett 2017,27(5),1319-1324","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=316","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1039\/C9MD00556K","volume":"11","author":"Liu H.","year":"2020","unstructured":"Liu H.; Jiang X.; Gao X.; Tian W.; Xu C.; Wang R.; Xu Y.; Wei L.; Cao F.; Li W.; Identification of N-benzothiazolyl-2-benzenesulfonamides as novel ABCA1 expression upregulators. RSC Med Chem 2020,11(3),411-418","journal-title":"RSC Med Chem"},{"key":"ref=317","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1080\/14756366.2020.1784892","volume":"35","author":"Sa&#x11F;l\u0131k B.N.","year":"2020","unstructured":"Sa&#x11F;l\u0131k B.N.; Osmaniye D.; Acar &#xC7;evik U.; Levent S.; Kaya &#xC7;avu&#x15F;o&#x11F;lu B.; Atl\u0131 Eklio&#x11F;lu &#xD6;.; &#xD6;zkay Y.; Koparal A.S.; Kaplanc\u0131kl\u0131 Z.A.; Synthesis, in vitro enzyme activity and molecular docking studies of new benzylamine-sulfonamide derivatives as selective MAO-B inhibitors. J Enzyme Inhib Med Chem 2020,35(1),1422-1432","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=318","doi-asserted-by":"publisher","first-page":"2842","DOI":"10.1007\/s00044-016-1707-7","volume":"25","author":"Singh A.","year":"2016","unstructured":"Singh A.; Yadav M.; Srivastava R.; Singh N.; Kaur R.; Gupta S.K.; Singh R.K.; Design and anti-HIV activity of arylsulphonamides as non-nucleoside reverse transcriptase inhibitors. Med Chem Res 2016,25(12),2842-2859","journal-title":"Med Chem Res"},{"key":"ref=319","doi-asserted-by":"publisher","first-page":"103960","DOI":"10.1016\/j.bioorg.2020.103960","volume":"101","author":"Djuidje E.N.","year":"2020","unstructured":"Djuidje E.N.; Sciabica S.; Buzzi R.; Dissette V.; Balzarini J.; Liekens S.; Serra E.; Andreotti E.; Manfredini S.; Vertuani S.; Baldisserotto A.; Design, synthesis and evaluation of benzothiazole derivatives as multifunctional agents. Bioorg Chem 2020,101,103960","journal-title":"Bioorg Chem"},{"key":"ref=320","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.3109\/14756366.2015.1128427","volume":"31","author":"Petrou A.","year":"2016","unstructured":"Petrou A.; Geronikaki A.; Terzi E.; Guler O.O.; Tuccinardi T.; Supuran C.T.; Inhibition of carbonic anhydrase isoforms I, II, IX and XII with secondary sulfonamides incorporating benzothiazole scaffolds. J Enzyme Inhib Med Chem 2016,31(6),1306-1311","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=321","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1111\/cbdd.13026","volume":"90","author":"Ammazzalorso A.","year":"2017","unstructured":"Ammazzalorso A.; De Lellis L.; Florio R.; Bruno I.; De Filippis B.; Fantacuzzi M.; Giampietro L.; Maccallini C.; Perconti S.; Verginelli F.; Cama A.; Amoroso R.; Cytotoxic effect of a family of peroxisome proliferator\u2010activated receptor antagonists in colorectal and pancreatic cancer cell lines. Chem Biol Drug Des 2017,90(5),1029-1035","journal-title":"Chem Biol Drug Des"},{"key":"ref=322","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1080\/14756366.2017.1356295","volume":"32","author":"Abdoli M.","year":"2017","unstructured":"Abdoli M.; Angeli A.; Bozdag M.; Carta F.; Kakanejadifard A.; Saeidian H.; Supuran C.T.; Synthesis and carbonic anhydrase I, II, VII, and IX inhibition studies with a series of benzo[d]thiazole-5- and 6-sulfonamides. J Enzyme Inhib Med Chem 2017,32(1),1071-1078","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=323","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/jccs.201800312","volume":"66","author":"Pawar C.D.","year":"2019","unstructured":"Pawar C.D.; Chavan S.L.; Pawar U.D.; Pansare D.N.; Deshmukh S.V.; Shinde D.B.; Synthesis, anti\u2010proliferative activity, SAR, and kinase inhibition studies of thiazol\u20102\u2010yl\u2010substituted sulfonamide derivatives. J Chin Chem Soc (Taipei) 2019,66(3),257-264","journal-title":"J Chin Chem Soc (Taipei)"},{"key":"ref=324","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1007\/s12539-016-0207-2","volume":"10","author":"Singh A.","year":"2018","unstructured":"Singh A.; Srivastava R.; Singh R.K.; Design, synthesis, and antibacterial activities of novel heterocyclic arylsulphonamide derivatives. Interdiscip Sci 2018,10(4),748-761","journal-title":"Interdiscip Sci"},{"key":"ref=325","first-page":"888","volume":"6","author":"Patil P.","year":"2013","unstructured":"Patil P.; Sethy S.; Sameena T.; Shailaja K.; Pyridine and its biological activity: A review. Asian J Res Chem 2013,6(10),888-899","journal-title":"Asian J Res Chem"},{"key":"ref=326","first-page":"1","volume":"1","author":"Altaf A.A.","year":"2015","unstructured":"Altaf A.A.; Shahzad A.; Gul Z.; Rasool N.; Badshah A.; Lal B.; Khan E.; A review on the medicinal importance of pyridine derivatives. J Drug Des Med Chem 2015,1(1),1-11","journal-title":"J Drug Des Med Chem"},{"key":"ref=327","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.saa.2014.06.145","volume":"135","author":"Helal M.H.","year":"2015","unstructured":"Helal M.H.; El-Awdan S.A.; Salem M.A.; Abd-elaziz T.A.; Moahamed Y.A.; El-Sherif A.A.; Mohamed G.A.M.; Synthesis, biological evaluation and molecular modeling of novel series of pyridine derivatives as anticancer, anti-inflammatory and analgesic agents. Spectrochim Acta A Mol Biomol Spectrosc 2015,135,764-773","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"key":"ref=328","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1007\/s12039-014-0671-3","volume":"126","author":"Ali A.","year":"2014","unstructured":"Ali A.; Bansal D.; Kaushik N.K.; Kaushik N.; Choi E.H.; Gupta R.; Syntheses, characterization, and anti-cancer activities of pyridine-amide based compounds containing appended phenol or catechol groups. J Chem Sci 2014,126(4),1091-1105","journal-title":"J Chem Sci"},{"key":"ref=329","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1039\/D0RA09400E","volume":"11","author":"Torabi M.","year":"2021","unstructured":"Torabi M.; Yarie M.; Zolfigol M.A.; Rouhani S.; Azizi S.; Olomola T.O.; Maaza M.; Msagati T.A.; Synthesis of new pyridines with sulfonamide moiety via a cooperative vinylogous anomeric-based oxidation mechanism in the presence of a novel quinoline-based dendrimer-like ionic liquid. RSC Advances 2021,11(5),3143-3152","journal-title":"RSC Advances"},{"key":"ref=330","doi-asserted-by":"publisher","first-page":"20926","DOI":"10.3390\/molecules201119740","volume":"20","author":"Zhou Z.","year":"2015","unstructured":"Zhou Z.; Li L.; Yan N.; Du L.; Sun C.; Sun T.; Synthesis, crystal structure, absolute configuration and antitumor activity of the enantiomers of 5-Bromo-2-chloro-N-(1-phenylethyl) pyridine-3-sulfonamide. Molecules 2015,20(11),20926-20938","journal-title":"Molecules"},{"key":"ref=331","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1134\/S107036321710022X","volume":"87","author":"El-Sayed H.","year":"2017","unstructured":"El-Sayed H.; Moustafa A.; El-Torky A.; El-Salam A.; A series of pyridines and pyridine based sulfa-drugs as antimicrobial agents: Design, synthesis and antimicrobial activity. Russ J Gen Chem 2017,87(10),2401-2408","journal-title":"Russ J Gen Chem"},{"key":"ref=332","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1016\/j.bmcl.2019.04.013","volume":"29","author":"Zhang K.","year":"2019","unstructured":"Zhang K.; Ni Y.; Chen J.; Tu Z.; Wu X.; Chen D.; Yao H.; Jiang S.; Discovery of trans-3-(pyridin-3-yl) acrylamide-derived sulfamides as potent nicotinamide phosphoribosyltransferase (NAMPT) inhibitors for the potential treatment of cancer. Bioorg Med Chem Lett 2019,29(12),1502-1506","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=333","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ejmech.2016.04.009","volume":"117","author":"Ghorab M.M.","year":"2016","unstructured":"Ghorab M.M.; Ragab F.A.; Heiba H.I.; Soliman A.M.; Design and synthesis of some novel 4-Chloro-N-(4-(1-(2-(2-cyanoacetyl) hydrazono) ethyl) phenyl) benzenesulfonamide derivatives as anticancer and radiosensitizing agents. Eur J Med Chem 2016,117,8-18","journal-title":"Eur J Med Chem"},{"key":"ref=334","doi-asserted-by":"publisher","first-page":"3828","DOI":"10.1021\/acs.jmedchem.7b00017","volume":"60","author":"Wang L.","year":"2017","unstructured":"Wang L.; Pratt J.K.; Soltwedel T.; Sheppard G.S.; Fidanze S.D.; Liu D.; Hasvold L.A.; Mantei R.A.; Holms J.H.; McClellan W.J.; Wendt M.D.; Wada C.; Frey R.; Hansen T.M.; Hubbard R.; Park C.H.; Li L.; Magoc T.J.; Albert D.H.; Lin X.; Warder S.E.; Kovar P.; Huang X.; Wilcox D.; Wang R.; Rajaraman G.; Petros A.M.; Hutchins C.W.; Panchal S.C.; Sun C.; Elmore S.W.; Shen Y.; Kati W.M.; McDaniel K.F.; Fragment-based, structure-enabled discovery of novel pyridones and pyridone macrocycles as potent bromodomain and extra-terminal domain (BET) family bromodomain inhibitors. J Med Chem 2017,60(9),3828-3850","journal-title":"J Med Chem"},{"key":"ref=335","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1134\/S1070428019120248","volume":"55","author":"Stellenboom N.","year":"2019","unstructured":"Stellenboom N.; Baykan A.; Synthesis and enzyme inhibitory activity of novel Pyridine-2, 6-dicarboxamides bearing primary sulfonamide groups. Russ J Org Chem 2019,55(12),1951-1956","journal-title":"Russ J Org Chem"},{"key":"ref=336","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.bioorg.2015.09.008","volume":"63","author":"Riaz S.","year":"2015","unstructured":"Riaz S.; Khan I.U.; Bajda M.; Ashraf M.; Shaukat A.; Rehman T.U.; Mutahir S.; Hussain S.; Mustafa G.; Yar M.; Pyridine sulfonamide as a small key organic molecule for the potential treatment of type-II diabetes mellitus and Alzheimer\u2019s disease: In vitro studies against yeast &#x3B1;-glucosidase, acetylcholinesterase and butyrylcholinesterase. Bioorg Chem 2015,63,64-71","journal-title":"Bioorg Chem"},{"key":"ref=337","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.molstruc.2016.11.048","volume":"1131","author":"Debbabi K.F.","year":"2017","unstructured":"Debbabi K.F.; Bashandy M.S.; Al-Harbi S.A.; Aljuhani E.H.; Al-Saidi H.M.; Synthesis and molecular docking against dihydrofolate reductase of novel pyridin-N-ethyl-N-methylbenzenesulfonamides as efficient anticancer and antimicrobial agents. J Mol Struct 2017,1131,124-135","journal-title":"J Mol Struct"},{"key":"ref=338","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1039\/C6MD00191B","volume":"7","author":"Pike A.","year":"2016","unstructured":"Pike A.; Storer R.I.; Owen R.M.; Armstrong E.; Benn C.L.; Bictash M.; Cheung K.F.; Costelloe K.; Dardennes E.; Impey E.; Milliken P.H.; Mortimer-Cassen E.; Pearce H.J.; The design, synthesis and evaluation of low molecular weight acidic sulfonamides as URAT1 inhibitors for the treatment of gout. MedChemComm 2016,7(8),1572-1579","journal-title":"MedChemComm"},{"key":"ref=339","doi-asserted-by":"publisher","first-page":"26182","DOI":"10.1021\/acsomega.0c03773","volume":"5","author":"Azzam R.A.","year":"2020","unstructured":"Azzam R.A.; Elsayed R.E.; Elgemeie G.H.; Design and synthesis of a new class of pyridine-based N-sulfonamides exhibiting antiviral, antimicrobial, and enzyme inhibition characteristics. ACS Omega 2020,5(40),26182-26194","journal-title":"ACS Omega"},{"key":"ref=340","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1016\/j.bmcl.2015.12.093","volume":"26","author":"Kang S-M.","year":"2016","unstructured":"Kang S-M.; Nam K-Y.; Jung S-Y.; Song K-H.; Kho S.; No K.T.; Choi H.K.; Song J-Y.; Inhibition of cancer cell invasion by new ((3, 4-dihydroxy benzylidene) hydrazinyl) pyridine-3-sulfonamide analogs. Bioorg Med Chem Lett 2016,26(4),1322-1328","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=341","doi-asserted-by":"publisher","first-page":"4657","DOI":"10.1007\/s11164-017-2903-x","volume":"43","author":"Ghorab M.M.","year":"2017","unstructured":"Ghorab M.M.; Ragab F.A.; Heiba H.I.; Soliman A.M.; Anticancer and radio-sensitizing evaluation of some new sulfonamide derivatives bearing pyridone, thiophene, and hydrazone moieties. Res Chem Intermed 2017,43(8),4657-4681","journal-title":"Res Chem Intermed"},{"key":"ref=342","doi-asserted-by":"publisher","first-page":"103153","DOI":"10.1016\/j.bioorg.2019.103153","volume":"91","author":"Sa&#x11F;l\u0131k B.N.","year":"2019","unstructured":"Sa&#x11F;l\u0131k B.N.; Cevik U.A.; Osmaniye D.; Levent S.; &#xC7;avu&#x15F;o&#x11F;lu B.K.; Demir Y.; Ilg\u0131n S.; &#xD6;zkay Y.; Koparal A.S.; Beydemir &#x15E;.; Kaplanc\u0131kl\u0131 Z.A.; Synthesis, molecular docking analysis and carbonic anhydrase I-II inhibitory evaluation of new sulfonamide derivatives. Bioorg Chem 2019,91,103153","journal-title":"Bioorg Chem"},{"key":"ref=343","doi-asserted-by":"publisher","first-page":"4676","DOI":"10.1021\/acs.jmedchem.6b00015","volume":"59","author":"Ku J-M.","year":"2016","unstructured":"Ku J-M.; Park K.; Lee J.H.; Cho K.J.; Nam Y-J.; Jeong D-Y.; Kim Y-H.; Kwon S.; Park J-Y.; Yang J.; Nam T.; Yoon S-H.; Ahn S.; Choi Y.; Discovery, optimization, and biological evaluation of sulfonamidoacetamides as an inducer of axon regeneration. J Med Chem 2016,59(10),4676-4687","journal-title":"J Med Chem"},{"key":"ref=344","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1016\/j.bmcl.2018.03.089","volume":"28","author":"Ghorab M.M.","year":"2018","unstructured":"Ghorab M.M.; Ragab F.A.; Heiba H.I.; El-Gazzar M.G.; El-Gazzar M.G.; Novel thioureido-benzenesulfonamide derivatives with enaminone linker as potent anticancer, radiosensitizers and VEGFR2 inhibitors. Bioorg Med Chem Lett 2018,28(9),1464-1470","journal-title":"Bioorg Med Chem Lett"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867329666220622153348","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/206295\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867329666220622153348","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T15:54:56Z","timestamp":1693670096000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/206295\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":344,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867329666220622153348","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-01-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-04-15","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-04-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-12-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}